Frequencies for first 10,000 rows of pt variable in reac2009q2 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 11 0.11 0.11 ABDOMINAL ABSCESS | 1 0.01 0.12 ABDOMINAL ADHESIONS | 3 0.03 0.15 ABDOMINAL DISCOMFORT | 11 0.11 0.26 ABDOMINAL DISTENSION | 10 0.10 0.36 ABDOMINAL MASS | 2 0.02 0.38 ABDOMINAL PAIN | 51 0.51 0.89 ABDOMINAL PAIN LOWER | 9 0.09 0.98 ABDOMINAL PAIN UPPER | 30 0.30 1.28 ABDOMINAL RIGIDITY | 1 0.01 1.29 ABDOMINAL TENDERNESS | 1 0.01 1.30 ABDOMINAL WALL ABSCESS | 1 0.01 1.31 ABNORMAL BEHAVIOUR | 20 0.20 1.51 ABNORMAL DREAMS | 3 0.03 1.54 ABNORMAL FAECES | 1 0.01 1.55 ABNORMAL LOSS OF WEIGHT | 1 0.01 1.56 ABNORMAL WEIGHT GAIN | 1 0.01 1.57 ABNORMAL WITHDRAWAL BLEEDING | 1 0.01 1.58 ABORTION | 2 0.02 1.60 ABORTION INDUCED | 5 0.05 1.65 ABORTION INDUCED COMPLICATED | 1 0.01 1.66 ABORTION SPONTANEOUS | 15 0.15 1.81 ABSCESS | 7 0.07 1.88 ABSCESS LIMB | 3 0.03 1.91 ABSCESS ORAL | 2 0.02 1.93 ACCIDENT | 4 0.04 1.97 ACCIDENTAL DRUG INTAKE BY CHILD | 3 0.03 2.00 ACCIDENTAL EXPOSURE | 3 0.03 2.03 ACCIDENTAL OVERDOSE | 7 0.07 2.10 ACIDOSIS | 3 0.03 2.13 ACNE | 3 0.03 2.16 ACNE CONGLOBATA | 1 0.01 2.17 ACNE PUSTULAR | 1 0.01 2.18 ACQUIRED HAEMOPHILIA | 1 0.01 2.19 ACTINIC KERATOSIS | 1 0.01 2.20 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 3 0.03 2.23 ACTIVATION SYNDROME | 3 0.03 2.26 ACTIVITIES OF DAILY LIVING IMPAIRED | 5 0.05 2.31 ACUTE ABDOMEN | 1 0.01 2.32 ACUTE CORONARY SYNDROME | 1 0.01 2.33 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 3 0.03 2.36 ACUTE GRAFT VERSUS HOST DISEASE | 2 0.02 2.38 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 2 0.02 2.40 ACUTE HEPATIC FAILURE | 2 0.02 2.42 ACUTE MYELOID LEUKAEMIA | 4 0.04 2.46 ACUTE MYOCARDIAL INFARCTION | 11 0.11 2.57 ACUTE PSYCHOSIS | 2 0.02 2.59 ACUTE PULMONARY OEDEMA | 1 0.01 2.60 ACUTE RESPIRATORY DISTRESS SYNDROME | 4 0.04 2.64 ACUTE RESPIRATORY FAILURE | 3 0.03 2.67 ACUTE RIGHT VENTRICULAR FAILURE | 1 0.01 2.68 ACUTE SINUSITIS | 1 0.01 2.69 ACUTE STRESS DISORDER | 1 0.01 2.70 ADACTYLY | 1 0.01 2.71 ADENOVIRUS INFECTION | 1 0.01 2.72 ADHESIOLYSIS | 1 0.01 2.73 ADJUSTMENT DISORDER | 1 0.01 2.74 ADRENAL DISORDER | 2 0.02 2.76 ADRENAL INSUFFICIENCY | 4 0.04 2.80 ADRENAL MASS | 2 0.02 2.82 ADRENOGENITAL SYNDROME | 1 0.01 2.83 ADVERSE DRUG REACTION | 4 0.04 2.87 ADVERSE EVENT | 3 0.03 2.90 AFFECT LABILITY | 1 0.01 2.91 AFFECTIVE DISORDER | 6 0.06 2.97 AFFERENT LOOP SYNDROME | 1 0.01 2.98 AGEUSIA | 3 0.03 3.01 AGGRESSION | 15 0.15 3.16 AGITATED DEPRESSION | 1 0.01 3.17 AGITATION | 23 0.23 3.40 AGORAPHOBIA | 2 0.02 3.42 AGRANULOCYTOSIS | 1 0.01 3.43 AIDS ENCEPHALOPATHY | 1 0.01 3.44 AIR EMBOLISM | 1 0.01 3.45 AKATHISIA | 5 0.05 3.50 ALANINE AMINOTRANSFERASE ABNORMAL | 1 0.01 3.51 ALANINE AMINOTRANSFERASE INCREASED | 22 0.22 3.73 ALCOHOL ABUSE | 1 0.01 3.74 ALCOHOL POISONING | 2 0.02 3.76 ALCOHOL USE | 1 0.01 3.77 ALCOHOLISATION PROCEDURE | 2 0.02 3.79 ALCOHOLISM | 1 0.01 3.80 ALLERGIC GRANULOMATOUS ANGIITIS | 1 0.01 3.81 ALOPECIA | 17 0.17 3.98 ALTERED STATE OF CONSCIOUSNESS | 7 0.07 4.05 ALTERED VISUAL DEPTH PERCEPTION | 1 0.01 4.06 ALVEOLITIS | 2 0.02 4.08 ALVEOLITIS ALLERGIC | 1 0.01 4.09 AMENORRHOEA | 4 0.04 4.13 AMMONIA INCREASED | 1 0.01 4.14 AMNESIA | 14 0.14 4.28 AMPHETAMINES POSITIVE | 1 0.01 4.29 AMYLOIDOSIS | 1 0.01 4.30 ANAEMIA | 48 0.48 4.78 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 2 0.02 4.80 ANAEMIA OF CHRONIC DISEASE | 1 0.01 4.81 ANAEMIA POSTOPERATIVE | 1 0.01 4.82 ANAL ABSCESS | 2 0.02 4.84 ANAL FISSURE | 2 0.02 4.86 ANALGESIC DRUG LEVEL INCREASED | 1 0.01 4.87 ANAPHYLACTIC REACTION | 7 0.07 4.94 ANAPHYLACTIC SHOCK | 8 0.08 5.02 ANASTOMOTIC LEAK | 1 0.01 5.03 ANDROGENETIC ALOPECIA | 1 0.01 5.04 ANEURYSM | 2 0.02 5.06 ANEURYSM RUPTURED | 2 0.02 5.08 ANGER | 14 0.14 5.22 ANGINA PECTORIS | 5 0.05 5.27 ANGINA UNSTABLE | 2 0.02 5.29 ANGIOEDEMA | 11 0.11 5.40 ANGIOPATHY | 1 0.01 5.41 ANGLE CLOSURE GLAUCOMA | 1 0.01 5.42 ANHEDONIA | 4 0.04 5.46 ANIMAL BITE | 1 0.01 5.47 ANION GAP DECREASED | 1 0.01 5.48 ANKLE FRACTURE | 2 0.02 5.50 ANORECTAL DISCOMFORT | 1 0.01 5.51 ANOREXIA | 29 0.29 5.80 ANORGASMIA | 1 0.01 5.81 ANOSMIA | 1 0.01 5.82 ANOXIC ENCEPHALOPATHY | 2 0.02 5.84 ANTEPARTUM HAEMORRHAGE | 3 0.03 5.87 ANTERIOR CHAMBER INFLAMMATION | 1 0.01 5.88 ANTI FACTOR V ANTIBODY POSITIVE | 1 0.01 5.89 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 2 0.02 5.91 ANTI-HBS ANTIBODY POSITIVE | 1 0.01 5.92 ANTI-INSULIN ANTIBODY | 1 0.01 5.93 ANTICOAGULATION DRUG LEVEL ABOVE THER.. | 2 0.02 5.95 ANTICONVULSANT DRUG LEVEL ABOVE THERA.. | 2 0.02 5.97 ANTICONVULSANT DRUG LEVEL DECREASED | 2 0.02 5.99 ANTIDIURETIC HORMONE ABNORMALITY | 1 0.01 6.00 ANTIMITOCHONDRIAL ANTIBODY POSITIVE | 1 0.01 6.01 ANTINUCLEAR ANTIBODY POSITIVE | 2 0.02 6.03 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAP.. | 3 0.03 6.06 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 2 0.02 6.08 ANURIA | 1 0.01 6.09 ANXIETY | 57 0.57 6.66 ANXIETY DISORDER | 1 0.01 6.67 ANXIETY DISORDER DUE TO A GENERAL MED.. | 1 0.01 6.68 AORTIC ANEURYSM | 1 0.01 6.69 AORTIC STENOSIS | 2 0.02 6.71 AORTIC VALVE DISEASE | 1 0.01 6.72 AORTIC VALVE INCOMPETENCE | 4 0.04 6.76 APATHY | 4 0.04 6.80 APHAGIA | 1 0.01 6.81 APHASIA | 4 0.04 6.85 APHONIA | 2 0.02 6.87 APHTHOUS STOMATITIS | 1 0.01 6.88 APLASIA | 2 0.02 6.90 APLASIA PURE RED CELL | 4 0.04 6.94 APLASTIC ANAEMIA | 2 0.02 6.96 APNOEA | 1 0.01 6.97 APPARENT DEATH | 2 0.02 6.99 APPENDICECTOMY | 1 0.01 7.00 APPENDICITIS | 9 0.09 7.09 APPENDICITIS PERFORATED | 1 0.01 7.10 APPLICATION SITE BLEEDING | 1 0.01 7.11 APPLICATION SITE BURN | 2 0.02 7.13 APPLICATION SITE ERYTHEMA | 2 0.02 7.15 APPLICATION SITE EXFOLIATION | 1 0.01 7.16 APPLICATION SITE HAEMATOMA | 1 0.01 7.17 APPLICATION SITE IRRITATION | 2 0.02 7.19 APPLICATION SITE PAIN | 1 0.01 7.20 APPLICATION SITE PRURITUS | 2 0.02 7.22 APPLICATION SITE REACTION | 2 0.02 7.24 APRAXIA | 1 0.01 7.25 ARACHNOIDITIS | 1 0.01 7.26 ARM AMPUTATION | 1 0.01 7.27 ARRESTED LABOUR | 1 0.01 7.28 ARRHYTHMIA | 18 0.18 7.46 ARTERIAL DISORDER | 1 0.01 7.47 ARTERIAL OCCLUSIVE DISEASE | 2 0.02 7.49 ARTERIAL THROMBOSIS LIMB | 1 0.01 7.50 ARTERIOSCLEROSIS | 6 0.06 7.56 ARTERIOSCLEROSIS CORONARY ARTERY | 2 0.02 7.58 ARTERIOSPASM CORONARY | 1 0.01 7.59 ARTERIOVENOUS FISTULA THROMBOSIS | 1 0.01 7.60 ARTERIOVENOUS GRAFT SITE INFECTION | 1 0.01 7.61 ARTERY DISSECTION | 1 0.01 7.62 ARTHRALGIA | 50 0.50 8.12 ARTHRITIS | 11 0.11 8.23 ARTHRITIS BACTERIAL | 1 0.01 8.24 ARTHROPATHY | 6 0.06 8.30 ARTHROPOD BITE | 2 0.02 8.32 ASCITES | 16 0.16 8.48 ASPARTATE AMINOTRANSFERASE INCREASED | 18 0.18 8.66 ASPHYXIA | 2 0.02 8.68 ASPIRATION | 3 0.03 8.71 ASTERIXIS | 1 0.01 8.72 ASTHENIA | 59 0.59 9.31 ASTHMA | 29 0.29 9.60 ASTHMATIC CRISIS | 1 0.01 9.61 ATAXIA | 3 0.03 9.64 ATELECTASIS | 5 0.05 9.69 ATRIAL FIBRILLATION | 19 0.19 9.88 ATRIAL FLUTTER | 1 0.01 9.89 ATRIAL HYPERTROPHY | 1 0.01 9.90 ATRIAL SEPTAL DEFECT | 12 0.12 10.02 ATRIOVENTRICULAR BLOCK | 3 0.03 10.05 ATRIOVENTRICULAR BLOCK COMPLETE | 4 0.04 10.09 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 3 0.03 10.12 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 3 0.03 10.15 AURA | 1 0.01 10.16 AUTISM | 1 0.01 10.17 AUTISM SPECTRUM DISORDER | 1 0.01 10.18 AUTOANTIBODY POSITIVE | 1 0.01 10.19 AUTOMATIC BLADDER | 1 0.01 10.20 AXILLARY PAIN | 1 0.01 10.21 AZOTAEMIA | 2 0.02 10.23 B-CELL LYMPHOMA | 1 0.01 10.24 B-LYMPHOCYTE COUNT DECREASED | 1 0.01 10.25 BACK INJURY | 1 0.01 10.26 BACK PAIN | 37 0.37 10.63 BACTERAEMIA | 4 0.04 10.67 BACTERIA STOOL IDENTIFIED | 1 0.01 10.68 BACTERIAL INFECTION | 2 0.02 10.70 BACTERIAL SEPSIS | 1 0.01 10.71 BALANCE DISORDER | 13 0.13 10.84 BASAL CELL CARCINOMA | 3 0.03 10.87 BED REST | 1 0.01 10.88 BEDRIDDEN | 1 0.01 10.89 BENIGN BREAST NEOPLASM | 1 0.01 10.90 BENIGN INTRACRANIAL HYPERTENSION | 3 0.03 10.93 BENIGN NEOPLASM | 1 0.01 10.94 BENIGN PROSTATIC HYPERPLASIA | 2 0.02 10.96 BICUSPID AORTIC VALVE | 1 0.01 10.97 BILE DUCT STENOSIS | 1 0.01 10.98 BILIARY DRAINAGE | 1 0.01 10.99 BILIARY DYSKINESIA | 1 0.01 11.00 BILIARY NEOPLASM | 1 0.01 11.01 BILIARY TRACT DISORDER | 1 0.01 11.02 BILIRUBIN CONJUGATED INCREASED | 1 0.01 11.03 BIOPSY BONE | 2 0.02 11.05 BIOPSY BONE MARROW | 1 0.01 11.06 BIPOLAR DISORDER | 7 0.07 11.13 BIPOLAR I DISORDER | 3 0.03 11.16 BIPOLAR II DISORDER | 1 0.01 11.17 BLADDER DISORDER | 3 0.03 11.20 BLADDER NEOPLASM | 1 0.01 11.21 BLADDER PAIN | 1 0.01 11.22 BLADDER PERFORATION | 1 0.01 11.23 BLINDNESS | 6 0.06 11.29 BLINDNESS TRANSIENT | 1 0.01 11.30 BLINDNESS UNILATERAL | 2 0.02 11.32 BLISTER | 7 0.07 11.39 BLOOD ALKALINE PHOSPHATASE | 1 0.01 11.40 BLOOD ALKALINE PHOSPHATASE INCREASED | 6 0.06 11.46 BLOOD AMYLASE INCREASED | 2 0.02 11.48 BLOOD BILIRUBIN ABNORMAL | 1 0.01 11.49 BLOOD BILIRUBIN INCREASED | 6 0.06 11.55 BLOOD CALCIUM ABNORMAL | 1 0.01 11.56 BLOOD CALCIUM DECREASED | 1 0.01 11.57 BLOOD CHLORIDE DECREASED | 1 0.01 11.58 BLOOD CHOLESTEROL DECREASED | 1 0.01 11.59 BLOOD CHOLESTEROL INCREASED | 13 0.13 11.72 BLOOD COUNT ABNORMAL | 4 0.04 11.76 BLOOD CREATINE INCREASED | 1 0.01 11.77 BLOOD CREATINE PHOSPHOKINASE INCREASED | 13 0.13 11.90 BLOOD CREATININE ABNORMAL | 1 0.01 11.91 BLOOD CREATININE DECREASED | 2 0.02 11.93 BLOOD CREATININE INCREASED | 15 0.15 12.08 BLOOD DISORDER | 2 0.02 12.10 BLOOD FIBRINOGEN INCREASED | 1 0.01 12.11 BLOOD GLUCOSE ABNORMAL | 1 0.01 12.12 BLOOD GLUCOSE DECREASED | 15 0.15 12.27 BLOOD GLUCOSE FLUCTUATION | 5 0.05 12.32 BLOOD GLUCOSE INCREASED | 29 0.29 12.61 BLOOD IRON INCREASED | 1 0.01 12.62 BLOOD LACTATE DEHYDROGENASE INCREASED | 3 0.03 12.65 BLOOD MAGNESIUM DECREASED | 1 0.01 12.66 BLOOD OSMOLARITY DECREASED | 3 0.03 12.69 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 12.70 BLOOD PHOSPHORUS INCREASED | 1 0.01 12.71 BLOOD POTASSIUM ABNORMAL | 1 0.01 12.72 BLOOD POTASSIUM DECREASED | 5 0.05 12.77 BLOOD POTASSIUM INCREASED | 4 0.04 12.81 BLOOD PRESSURE ABNORMAL | 2 0.02 12.83 BLOOD PRESSURE DECREASED | 6 0.06 12.89 BLOOD PRESSURE DIASTOLIC DECREASED | 1 0.01 12.90 BLOOD PRESSURE FLUCTUATION | 2 0.02 12.92 BLOOD PRESSURE IMMEASURABLE | 1 0.01 12.93 BLOOD PRESSURE INADEQUATELY CONTROLLED | 4 0.04 12.97 BLOOD PRESSURE INCREASED | 27 0.27 13.24 BLOOD PRESSURE SYSTOLIC DECREASED | 2 0.02 13.26 BLOOD PRESSURE SYSTOLIC INCREASED | 2 0.02 13.28 BLOOD PROLACTIN INCREASED | 1 0.01 13.29 BLOOD SODIUM DECREASED | 3 0.03 13.32 BLOOD STEM CELL TRANSPLANT FAILURE | 1 0.01 13.33 BLOOD TEST ABNORMAL | 1 0.01 13.34 BLOOD THROMBIN | 1 0.01 13.35 BLOOD TRIGLYCERIDES INCREASED | 7 0.07 13.42 BLOOD UREA DECREASED | 1 0.01 13.43 BLOOD UREA INCREASED | 6 0.06 13.49 BLOOD URIC ACID INCREASED | 1 0.01 13.50 BLOOD URINE | 1 0.01 13.51 BLOOD URINE PRESENT | 5 0.05 13.56 BODY HEIGHT DECREASED | 5 0.05 13.61 BODY TEMPERATURE DECREASED | 2 0.02 13.63 BODY TEMPERATURE INCREASED | 3 0.03 13.66 BONE CYST | 1 0.01 13.67 BONE DISORDER | 6 0.06 13.73 BONE GRAFT | 1 0.01 13.74 BONE MARROW FAILURE | 5 0.05 13.79 BONE MARROW OEDEMA | 1 0.01 13.80 BONE MARROW OEDEMA SYNDROME | 1 0.01 13.81 BONE MARROW TUMOUR CELL INFILTRATION | 1 0.01 13.82 BONE NEOPLASM MALIGNANT | 2 0.02 13.84 BONE OPERATION | 2 0.02 13.86 BONE PAIN | 15 0.15 14.01 BOVINE TUBERCULOSIS | 2 0.02 14.03 BRADYARRHYTHMIA | 1 0.01 14.04 BRADYCARDIA | 13 0.13 14.17 BRADYCARDIA NEONATAL | 1 0.01 14.18 BRADYPHRENIA | 2 0.02 14.20 BRAIN DEATH | 1 0.01 14.21 BRAIN HERNIATION | 1 0.01 14.22 BRAIN INJURY | 3 0.03 14.25 BRAIN NATRIURETIC PEPTIDE INCREASED | 2 0.02 14.27 BRAIN NEOPLASM MALIGNANT | 1 0.01 14.28 BRAIN OEDEMA | 1 0.01 14.29 BREAST ABSCESS | 1 0.01 14.30 BREAST CANCER | 37 0.37 14.67 BREAST CANCER FEMALE | 20 0.20 14.87 BREAST CANCER IN SITU | 2 0.02 14.89 BREAST CANCER METASTATIC | 16 0.16 15.05 BREAST CYST | 1 0.01 15.06 BREAST DISORDER | 1 0.01 15.07 BREAST HAEMATOMA | 1 0.01 15.08 BREAST MASS | 5 0.05 15.13 BREAST PAIN | 1 0.01 15.14 BREAST TENDERNESS | 1 0.01 15.15 BREATH ODOUR | 1 0.01 15.16 BREATH SOUNDS ABNORMAL | 2 0.02 15.18 BRONCHIECTASIS | 2 0.02 15.20 BRONCHIOLITIS | 1 0.01 15.21 BRONCHITIS | 16 0.16 15.37 BRONCHITIS CHRONIC | 2 0.02 15.39 BRONCHOPNEUMONIA | 3 0.03 15.42 BRONCHOSPASM | 4 0.04 15.46 BRUGADA SYNDROME | 2 0.02 15.48 BRUXISM | 1 0.01 15.49 BUNDLE BRANCH BLOCK LEFT | 1 0.01 15.50 BUNDLE BRANCH BLOCK RIGHT | 5 0.05 15.55 BURNING SENSATION | 6 0.06 15.61 BURNING SENSATION MUCOSAL | 1 0.01 15.62 BURNS THIRD DEGREE | 1 0.01 15.63 BURSITIS INFECTIVE | 1 0.01 15.64 C-REACTIVE PROTEIN INCREASED | 6 0.06 15.70 CACHEXIA | 3 0.03 15.73 CAESAREAN SECTION | 3 0.03 15.76 CALCINOSIS | 1 0.01 15.77 CALCULUS URINARY | 1 0.01 15.78 CANDIDA SEPSIS | 1 0.01 15.79 CARDIAC ARREST | 16 0.16 15.95 CARDIAC DISORDER | 17 0.17 16.12 CARDIAC ENZYMES INCREASED | 2 0.02 16.14 CARDIAC FAILURE | 18 0.18 16.32 CARDIAC FAILURE CONGESTIVE | 37 0.37 16.69 CARDIAC FLUTTER | 1 0.01 16.70 CARDIAC INFECTION | 1 0.01 16.71 CARDIAC MURMUR | 11 0.11 16.82 CARDIAC OPERATION | 2 0.02 16.84 CARDIAC PACEMAKER INSERTION | 2 0.02 16.86 CARDIAC RESYNCHRONISATION THERAPY | 1 0.01 16.87 CARDIAC TAMPONADE | 1 0.01 16.88 CARDIAC VALVE DISEASE | 4 0.04 16.92 CARDIO-RESPIRATORY ARREST | 6 0.06 16.98 CARDIO-RESPIRATORY ARREST NEONATAL | 1 0.01 16.99 CARDIOACTIVE DRUG LEVEL INCREASED | 1 0.01 17.00 CARDIOGENIC SHOCK | 2 0.02 17.02 CARDIOMEGALY | 8 0.08 17.10 CARDIOMYOPATHY | 5 0.05 17.15 CARDIOTOXICITY | 3 0.03 17.18 CARDIOVASCULAR DISORDER | 4 0.04 17.22 CARDIOVASCULAR INSUFFICIENCY | 1 0.01 17.23 CARDIOVERSION | 1 0.01 17.24 CAROTID ARTERY OCCLUSION | 1 0.01 17.25 CARPAL TUNNEL SYNDROME | 2 0.02 17.27 CARTILAGE INJURY | 1 0.01 17.28 CATARACT | 4 0.04 17.32 CATARACT OPERATION | 2 0.02 17.34 CATATONIA | 1 0.01 17.35 CATHETER PLACEMENT | 1 0.01 17.36 CATHETER RELATED COMPLICATION | 3 0.03 17.39 CATHETER RELATED INFECTION | 3 0.03 17.42 CATHETER SEPSIS | 4 0.04 17.46 CATHETER SITE INFECTION | 1 0.01 17.47 CATHETER THROMBOSIS | 3 0.03 17.50 CATHETERISATION CARDIAC | 2 0.02 17.52 CAUSTIC INJURY | 1 0.01 17.53 CD8 LYMPHOCYTES INCREASED | 1 0.01 17.54 CELLULITIS | 17 0.17 17.71 CENTRAL NERVOUS SYSTEM LESION | 3 0.03 17.74 CENTRAL VENOUS CATHETERISATION | 2 0.02 17.76 CEPHALHAEMATOMA | 1 0.01 17.77 CEREBELLAR INFARCTION | 2 0.02 17.79 CEREBRAL ARTERY THROMBOSIS | 1 0.01 17.80 CEREBRAL ATROPHY | 3 0.03 17.83 CEREBRAL DISORDER | 1 0.01 17.84 CEREBRAL HAEMATOMA | 3 0.03 17.87 CEREBRAL HAEMORRHAGE | 11 0.11 17.98 CEREBRAL INFARCTION | 9 0.09 18.07 CEREBRAL ISCHAEMIA | 2 0.02 18.09 CEREBRAL THROMBOSIS | 1 0.01 18.10 CEREBROVASCULAR ACCIDENT | 34 0.34 18.44 CEREBROVASCULAR DISORDER | 1 0.01 18.45 CERUMEN IMPACTION | 1 0.01 18.46 CERVICAL DYSPLASIA | 2 0.02 18.48 CERVICITIS | 1 0.01 18.49 CERVIX DISORDER | 1 0.01 18.50 CHAPPED LIPS | 1 0.01 18.51 CHEILITIS | 2 0.02 18.53 CHEST DISCOMFORT | 19 0.19 18.72 CHEST INJURY | 2 0.02 18.74 CHEST PAIN | 60 0.60 19.34 CHEST X-RAY ABNORMAL | 1 0.01 19.35 CHILLS | 22 0.22 19.57 CHOKING | 4 0.04 19.61 CHOLECYSTITIS | 3 0.03 19.64 CHOLELITHIASIS | 5 0.05 19.69 CHOLESTASIS | 2 0.02 19.71 CHOLESTATIC LIVER INJURY | 1 0.01 19.72 CHOREOATHETOSIS | 1 0.01 19.73 CHORIORETINOPATHY | 1 0.01 19.74 CHOROID MELANOMA | 1 0.01 19.75 CHROMATURIA | 8 0.08 19.83 CHRONIC GRAFT VERSUS HOST DISEASE | 3 0.03 19.86 CHRONIC HEPATIC FAILURE | 1 0.01 19.87 CHRONIC LYMPHOCYTIC LEUKAEMIA | 1 0.01 19.88 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 20 0.20 20.08 CHRONIC SINUSITIS | 2 0.02 20.10 CHYLOTHORAX | 1 0.01 20.11 CIRCULATORY COLLAPSE | 1 0.01 20.12 CLAUSTROPHOBIA | 2 0.02 20.14 CLAVICLE FRACTURE | 1 0.01 20.15 CLEFT LIP | 1 0.01 20.16 CLEFT PALATE | 1 0.01 20.17 CLINODACTYLY | 1 0.01 20.18 CLONIC CONVULSION | 1 0.01 20.19 CLOSTRIDIAL INFECTION | 8 0.08 20.27 CLOSTRIDIUM DIFFICILE COLITIS | 4 0.04 20.31 COAGULATION FACTOR V LEVEL DECREASED | 1 0.01 20.32 COAGULOPATHY | 4 0.04 20.36 COARCTATION OF THE AORTA | 2 0.02 20.38 COCCYDYNIA | 2 0.02 20.40 COGNITIVE DISORDER | 7 0.07 20.47 COLD SWEAT | 5 0.05 20.52 COLITIS | 9 0.09 20.61 COLITIS ISCHAEMIC | 3 0.03 20.64 COLITIS ULCERATIVE | 4 0.04 20.68 COLON ADENOMA | 2 0.02 20.70 COLON CANCER | 4 0.04 20.74 COLON CANCER METASTATIC | 1 0.01 20.75 COLON OPERATION | 2 0.02 20.77 COLONIC POLYP | 2 0.02 20.79 COLONIC STENOSIS | 1 0.01 20.80 COLONOSCOPY ABNORMAL | 1 0.01 20.81 COMA | 6 0.06 20.87 COMMINUTED FRACTURE | 1 0.01 20.88 COMMUNICATION DISORDER | 2 0.02 20.90 COMPARTMENT SYNDROME | 1 0.01 20.91 COMPLETED SUICIDE | 9 0.09 21.00 COMPLEX PARTIAL SEIZURES | 1 0.01 21.01 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 21.02 COMPLICATION OF DELIVERY | 2 0.02 21.04 COMPLICATION OF PREGNANCY | 1 0.01 21.05 COMPLICATIONS OF TRANSPLANTED KIDNEY | 1 0.01 21.06 COMPULSIVE SHOPPING | 2 0.02 21.08 COMPUTERISED TOMOGRAM ABNORMAL | 2 0.02 21.10 CONCOMITANT DISEASE PROGRESSION | 2 0.02 21.12 CONCUSSION | 1 0.01 21.13 CONDITION AGGRAVATED | 17 0.17 21.30 CONFUSIONAL STATE | 32 0.32 21.62 CONGENITAL ANOMALY | 3 0.03 21.65 CONGENITAL AORTIC STENOSIS | 1 0.01 21.66 CONGENITAL CENTRAL NERVOUS SYSTEM ANO.. | 2 0.02 21.68 CONGENITAL CORONARY ARTERY MALFORMATION | 1 0.01 21.69 CONGENITAL CYST | 1 0.01 21.70 CONGENITAL DIAPHRAGMATIC HERNIA | 1 0.01 21.71 CONGENITAL FOOT MALFORMATION | 1 0.01 21.72 CONGENITAL HAND MALFORMATION | 1 0.01 21.73 CONGENITAL MITRAL VALVE STENOSIS | 1 0.01 21.74 CONGENITAL TRICUSPID VALVE ATRESIA | 1 0.01 21.75 CONGESTIVE CARDIOMYOPATHY | 2 0.02 21.77 CONJUNCTIVITIS | 1 0.01 21.78 CONJUNCTIVITIS ALLERGIC | 1 0.01 21.79 CONJUNCTIVITIS VIRAL | 1 0.01 21.80 CONNECTIVE TISSUE DISORDER | 1 0.01 21.81 CONSTIPATION | 32 0.32 22.13 CONTRACTED BLADDER | 1 0.01 22.14 CONTRALATERAL BREAST CANCER | 1 0.01 22.15 CONTUSION | 13 0.13 22.28 CONVERSION DISORDER | 1 0.01 22.29 CONVULSION | 55 0.55 22.84 CONVULSIONS LOCAL | 1 0.01 22.85 COORDINATION ABNORMAL | 4 0.04 22.89 COR PULMONALE | 1 0.01 22.90 CORNEAL ABRASION | 2 0.02 22.92 CORONARY ANGIOPLASTY | 2 0.02 22.94 CORONARY ARTERIAL STENT INSERTION | 1 0.01 22.95 CORONARY ARTERY BYPASS | 1 0.01 22.96 CORONARY ARTERY DISEASE | 14 0.14 23.10 CORONARY ARTERY OCCLUSION | 6 0.06 23.16 CORONARY ARTERY STENOSIS | 2 0.02 23.18 CORONARY REVASCULARISATION | 1 0.01 23.19 COUGH | 41 0.41 23.60 CRANIOSYNOSTOSIS | 1 0.01 23.61 CREATININE RENAL CLEARANCE DECREASED | 2 0.02 23.63 CROHN'S DISEASE | 11 0.11 23.74 CRYING | 10 0.10 23.84 CSF CELL COUNT INCREASED | 1 0.01 23.85 CULTURE WOUND POSITIVE | 1 0.01 23.86 CUSHING'S SYNDROME | 1 0.01 23.87 CYANOSIS | 9 0.09 23.96 CYST | 2 0.02 23.98 CYSTITIS | 7 0.07 24.05 CYSTITIS BACTERIAL | 1 0.01 24.06 CYSTOCELE | 1 0.01 24.07 CYSTOSARCOMA PHYLLODES | 1 0.01 24.08 CYTOLYTIC HEPATITIS | 1 0.01 24.09 CYTOMEGALOVIRUS COLITIS | 1 0.01 24.10 CYTOMEGALOVIRUS INFECTION | 2 0.02 24.12 DANDRUFF | 1 0.01 24.13 DEAFNESS | 5 0.05 24.18 DEAFNESS NEUROSENSORY | 1 0.01 24.19 DEAFNESS UNILATERAL | 2 0.02 24.21 DEATH | 135 1.35 25.56 DECREASED ACTIVITY | 3 0.03 25.59 DECREASED APPETITE | 13 0.13 25.72 DECUBITUS ULCER | 5 0.05 25.77 DEEP VEIN THROMBOSIS | 9 0.09 25.86 DEFORMITY | 2 0.02 25.88 DEHYDRATION | 46 0.46 26.34 DELIRIUM | 9 0.09 26.43 DELIRIUM TREMENS | 1 0.01 26.44 DELUSION | 10 0.10 26.54 DELUSION OF GRANDEUR | 1 0.01 26.55 DEMENTIA | 5 0.05 26.60 DEMENTIA ALZHEIMER'S TYPE | 2 0.02 26.62 DEMYELINATION | 1 0.01 26.63 DENTAL CARIES | 5 0.05 26.68 DENTAL DISCOMFORT | 1 0.01 26.69 DENTAL IMPLANTATION | 1 0.01 26.70 DENTAL OPERATION | 1 0.01 26.71 DEPRESSED LEVEL OF CONSCIOUSNESS | 14 0.14 26.85 DEPRESSED MOOD | 9 0.09 26.94 DEPRESSION | 46 0.46 27.40 DEREALISATION | 1 0.01 27.41 DERMAL CYST | 1 0.01 27.42 DERMATITIS | 3 0.03 27.45 DERMATITIS ALLERGIC | 2 0.02 27.47 DERMATITIS BULLOUS | 2 0.02 27.49 DERMATITIS CONTACT | 3 0.03 27.52 DERMATITIS EXFOLIATIVE | 5 0.05 27.57 DERMATITIS HERPETIFORMIS | 1 0.01 27.58 DERMATITIS PSORIASIFORM | 1 0.01 27.59 DEVELOPMENTAL DELAY | 1 0.01 27.60 DEVICE BREAKAGE | 2 0.02 27.62 DEVICE CONNECTION ISSUE | 1 0.01 27.63 DEVICE DISLOCATION | 1 0.01 27.64 DEVICE FAILURE | 2 0.02 27.66 DEVICE MALFUNCTION | 1 0.01 27.67 DIABETES INSIPIDUS | 1 0.01 27.68 DIABETES MELLITUS | 62 0.62 28.30 DIABETES MELLITUS INADEQUATE CONTROL | 5 0.05 28.35 DIABETIC COMA | 3 0.03 28.38 DIABETIC COMPLICATION | 2 0.02 28.40 DIABETIC FOOT | 2 0.02 28.42 DIABETIC HYPERGLYCAEMIC COMA | 1 0.01 28.43 DIABETIC KETOACIDOSIS | 7 0.07 28.50 DIABETIC NEUROPATHY | 2 0.02 28.52 DIABETIC RETINOPATHY | 2 0.02 28.54 DIALYSIS | 1 0.01 28.55 DIAPHRAGMATIC DISORDER | 1 0.01 28.56 DIARRHOEA | 69 0.69 29.25 DIARRHOEA HAEMORRHAGIC | 1 0.01 29.26 DIFFERENTIAL WHITE BLOOD CELL COUNT A.. | 1 0.01 29.27 DIFFUSE ALVEOLAR DAMAGE | 1 0.01 29.28 DIFFUSE LARGE B-CELL LYMPHOMA STAGE III | 1 0.01 29.29 DILATATION VENTRICULAR | 2 0.02 29.31 DIPLOPIA | 1 0.01 29.32 DISABILITY | 2 0.02 29.34 DISCOMFORT | 4 0.04 29.38 DISEASE PROGRESSION | 19 0.19 29.57 DISEASE RECURRENCE | 3 0.03 29.60 DISORIENTATION | 11 0.11 29.71 DISSEMINATED INTRAVASCULAR COAGULATION | 4 0.04 29.75 DISSEMINATED TUBERCULOSIS | 1 0.01 29.76 DISSOCIATION | 1 0.01 29.77 DISSOCIATIVE DISORDER | 1 0.01 29.78 DISTURBANCE IN ATTENTION | 9 0.09 29.87 DISTURBANCE IN SOCIAL BEHAVIOUR | 1 0.01 29.88 DIVERTICULITIS | 7 0.07 29.95 DIVERTICULITIS INTESTINAL HAEMORRHAGIC | 1 0.01 29.96 DIVERTICULUM | 3 0.03 29.99 DIVERTICULUM INTESTINAL | 2 0.02 30.01 DIZZINESS | 75 0.75 30.76 DIZZINESS POSTURAL | 1 0.01 30.77 DOCUMENTED HYPERSENSITIVITY TO ADMINI.. | 1 0.01 30.78 DOUBLE OUTLET RIGHT VENTRICLE | 3 0.03 30.81 DRUG ABUSE | 1 0.01 30.82 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 1 0.01 30.83 DRUG ADMINISTRATION ERROR | 7 0.07 30.90 DRUG CLEARANCE DECREASED | 1 0.01 30.91 DRUG DELIVERY SYSTEM MALFUNCTION | 1 0.01 30.92 DRUG DEPENDENCE | 6 0.06 30.98 DRUG DISPENSING ERROR | 2 0.02 31.00 DRUG DOSE OMISSION | 2 0.02 31.02 DRUG EFFECT DECREASED | 13 0.13 31.15 DRUG EFFECT INCREASED | 2 0.02 31.17 DRUG ERUPTION | 4 0.04 31.21 DRUG EXPOSURE DURING PREGNANCY | 50 0.50 31.71 DRUG HYPERSENSITIVITY | 4 0.04 31.75 DRUG INEFFECTIVE | 133 1.33 33.08 DRUG INTERACTION | 44 0.44 33.52 DRUG INTOLERANCE | 5 0.05 33.57 DRUG LEVEL ABOVE THERAPEUTIC | 3 0.03 33.60 DRUG LEVEL CHANGED | 1 0.01 33.61 DRUG LEVEL DECREASED | 1 0.01 33.62 DRUG LEVEL INCREASED | 2 0.02 33.64 DRUG PRESCRIBING ERROR | 2 0.02 33.66 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 4 0.04 33.70 DRUG SCREEN FALSE POSITIVE | 1 0.01 33.71 DRUG SCREEN POSITIVE | 2 0.02 33.73 DRUG TOXICITY | 11 0.11 33.84 DRUG WITHDRAWAL SYNDROME | 7 0.07 33.91 DRUG WITHDRAWAL SYNDROME NEONATAL | 2 0.02 33.93 DRY EYE | 6 0.06 33.99 DRY MOUTH | 12 0.12 34.11 DRY SKIN | 6 0.06 34.17 DRY THROAT | 2 0.02 34.19 DUODENAL ULCER | 2 0.02 34.21 DUODENAL ULCER PERFORATION | 1 0.01 34.22 DYSARTHRIA | 11 0.11 34.33 DYSGEUSIA | 6 0.06 34.39 DYSGRAPHIA | 1 0.01 34.40 DYSKINESIA | 8 0.08 34.48 DYSLEXIA | 1 0.01 34.49 DYSLIPIDAEMIA | 1 0.01 34.50 DYSMENORRHOEA | 2 0.02 34.52 DYSMORPHISM | 2 0.02 34.54 DYSPAREUNIA | 1 0.01 34.55 DYSPEPSIA | 15 0.15 34.70 DYSPHAGIA | 30 0.30 35.00 DYSPHEMIA | 1 0.01 35.01 DYSPHONIA | 7 0.07 35.08 DYSPHORIA | 2 0.02 35.10 DYSPNOEA | 126 1.26 36.36 DYSPNOEA EXERTIONAL | 3 0.03 36.39 DYSPNOEA PAROXYSMAL NOCTURNAL | 1 0.01 36.40 DYSSTASIA | 5 0.05 36.45 DYSTHYMIC DISORDER | 1 0.01 36.46 DYSTONIA | 4 0.04 36.50 DYSURIA | 13 0.13 36.63 EAR DISCOMFORT | 1 0.01 36.64 EAR INFECTION | 3 0.03 36.67 EAR PAIN | 6 0.06 36.73 EAR TUBE INSERTION | 1 0.01 36.74 EATING DISORDER | 6 0.06 36.80 EBSTEIN'S ANOMALY | 1 0.01 36.81 ECCHYMOSIS | 3 0.03 36.84 ECTOPIC PREGNANCY | 1 0.01 36.85 ECTOPIC PREGNANCY WITH INTRAUTERINE D.. | 4 0.04 36.89 ECZEMA | 6 0.06 36.95 EDUCATIONAL PROBLEM | 1 0.01 36.96 EJACULATION DISORDER | 1 0.01 36.97 EJACULATION FAILURE | 1 0.01 36.98 EJECTION FRACTION DECREASED | 2 0.02 37.00 ELECTROCARDIOGRAM ABNORMAL | 3 0.03 37.03 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 37.04 ELECTROCARDIOGRAM QT PROLONGED | 7 0.07 37.11 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 2 0.02 37.13 ELECTROCARDIOGRAM T WAVE INVERSION | 1 0.01 37.14 ELECTROENCEPHALOGRAM ABNORMAL | 1 0.01 37.15 ELECTROLYTE IMBALANCE | 4 0.04 37.19 EMBOLIC STROKE | 1 0.01 37.20 EMBOLISM | 1 0.01 37.21 EMOTIONAL DISORDER | 10 0.10 37.31 EMOTIONAL DISTRESS | 11 0.11 37.42 ENAMEL ANOMALY | 1 0.01 37.43 ENCEPHALOPATHY | 4 0.04 37.47 ENDOCRINE NEOPLASM MALIGNANT | 2 0.02 37.49 ENDODONTIC PROCEDURE | 1 0.01 37.50 ENDOMETRIAL HYPERPLASIA | 1 0.01 37.51 ENDOMETRIAL HYPERTROPHY | 2 0.02 37.53 ENDOSCOPY GASTROINTESTINAL | 1 0.01 37.54 ENDOTRACHEAL INTUBATION | 1 0.01 37.55 ENTERITIS | 1 0.01 37.56 ENTEROBACTER INFECTION | 1 0.01 37.57 ENTEROCOCCAL INFECTION | 1 0.01 37.58 ENTEROCOLITIS HAEMORRHAGIC | 1 0.01 37.59 ENURESIS | 2 0.02 37.61 EOSINOPHIL COUNT INCREASED | 2 0.02 37.63 EOSINOPHILIA | 3 0.03 37.66 EOSINOPHILIC PNEUMONIA | 1 0.01 37.67 EOSINOPHILIC PNEUMONIA ACUTE | 1 0.01 37.68 EPICONDYLITIS | 1 0.01 37.69 EPIDIDYMITIS | 3 0.03 37.72 EPIDURAL ANAESTHESIA | 1 0.01 37.73 EPILEPSY | 3 0.03 37.76 EPISTAXIS | 12 0.12 37.88 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOP.. | 3 0.03 37.91 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 37.93 ERECTILE DYSFUNCTION | 5 0.05 37.98 ERUCTATION | 2 0.02 38.00 ERYTHEMA | 27 0.27 38.27 ERYTHEMA MULTIFORME | 3 0.03 38.30 ERYTHEMA NODOSUM | 1 0.01 38.31 ERYTHRASMA | 1 0.01 38.32 ESCHERICHIA BACTERAEMIA | 2 0.02 38.34 ESSENTIAL HYPERTENSION | 1 0.01 38.35 EUPHORIC MOOD | 4 0.04 38.39 EXCORIATION | 2 0.02 38.41 EXERCISE LACK OF | 2 0.02 38.43 EXERCISE TOLERANCE DECREASED | 1 0.01 38.44 EXOSTOSIS | 3 0.03 38.47 EXPIRED DRUG ADMINISTERED | 3 0.03 38.50 EXTRADURAL ABSCESS | 1 0.01 38.51 EXTRAPYRAMIDAL DISORDER | 2 0.02 38.53 EXTRASYSTOLES | 2 0.02 38.55 EXTRAVASATION | 1 0.01 38.56 EXTREMITY NECROSIS | 1 0.01 38.57 EYE DISORDER | 3 0.03 38.60 EYE HAEMORRHAGE | 3 0.03 38.63 EYE INFECTION | 2 0.02 38.65 EYE INFECTION STAPHYLOCOCCAL | 1 0.01 38.66 EYE INFLAMMATION | 2 0.02 38.68 EYE IRRITATION | 4 0.04 38.72 EYE MOVEMENT DISORDER | 1 0.01 38.73 EYE OPERATION | 2 0.02 38.75 EYE PAIN | 6 0.06 38.81 EYE PRURITUS | 5 0.05 38.86 EYE SWELLING | 4 0.04 38.90 EYEBALL RUPTURE | 1 0.01 38.91 EYELID DISORDER | 1 0.01 38.92 EYELID OEDEMA | 1 0.01 38.93 EYELID OPERATION | 1 0.01 38.94 EYELID PTOSIS | 1 0.01 38.95 FACE INJURY | 1 0.01 38.96 FACE OEDEMA | 6 0.06 39.02 FACIAL BONES FRACTURE | 1 0.01 39.03 FACIAL PAIN | 1 0.01 39.04 FACIAL PALSY | 4 0.04 39.08 FACIAL PARESIS | 2 0.02 39.10 FACTOR V DEFICIENCY | 1 0.01 39.11 FAECAL INCONTINENCE | 2 0.02 39.13 FAECALITH | 1 0.01 39.14 FAECES DISCOLOURED | 6 0.06 39.20 FAECES PALE | 2 0.02 39.22 FAILURE OF IMPLANT | 1 0.01 39.23 FAILURE TO THRIVE | 4 0.04 39.27 FALL | 59 0.59 39.86 FALLOT'S TETRALOGY | 1 0.01 39.87 FAMILY STRESS | 2 0.02 39.89 FASCIITIS | 1 0.01 39.90 FAT REDISTRIBUTION | 1 0.01 39.91 FAT TISSUE INCREASED | 1 0.01 39.92 FATIGUE | 69 0.69 40.61 FEAR | 5 0.05 40.66 FEBRILE BONE MARROW APLASIA | 1 0.01 40.67 FEBRILE INFECTION | 1 0.01 40.68 FEBRILE NEUTROPENIA | 17 0.17 40.85 FEEDING DISORDER NEONATAL | 2 0.02 40.87 FEELING ABNORMAL | 32 0.32 41.19 FEELING COLD | 2 0.02 41.21 FEELING DRUNK | 1 0.01 41.22 FEELING HOT | 6 0.06 41.28 FEELING JITTERY | 7 0.07 41.35 FEELING OF BODY TEMPERATURE CHANGE | 3 0.03 41.38 FEELINGS OF WORTHLESSNESS | 2 0.02 41.40 FELTY'S SYNDROME | 1 0.01 41.41 FEMORAL NECK FRACTURE | 4 0.04 41.45 FEMUR FRACTURE | 5 0.05 41.50 FIBRIN D DIMER INCREASED | 1 0.01 41.51 FIBRINOLYSIS INCREASED | 1 0.01 41.52 FIBROCYSTIC BREAST DISEASE | 2 0.02 41.54 FIBROMYALGIA | 6 0.06 41.60 FIBROSARCOMA | 1 0.01 41.61 FIBROSIS | 4 0.04 41.65 FIBULA FRACTURE | 1 0.01 41.66 FINGER DEFORMITY | 1 0.01 41.67 FISTULA | 2 0.02 41.69 FLANK PAIN | 2 0.02 41.71 FLATULENCE | 4 0.04 41.75 FLIGHT OF IDEAS | 1 0.01 41.76 FLUID INTAKE REDUCED | 2 0.02 41.78 FLUID OVERLOAD | 4 0.04 41.82 FLUID RETENTION | 4 0.04 41.86 FLUSHING | 8 0.08 41.94 FOETAL ARRHYTHMIA | 1 0.01 41.95 FOETAL CHROMOSOME ABNORMALITY | 1 0.01 41.96 FOETAL MALFORMATION | 1 0.01 41.97 FOLLICULITIS | 1 0.01 41.98 FONTANELLE BULGING | 1 0.01 41.99 FOOD AVERSION | 1 0.01 42.00 FOOD CRAVING | 1 0.01 42.01 FOOD INTOLERANCE | 1 0.01 42.02 FOOD POISONING | 3 0.03 42.05 FOOT DEFORMITY | 1 0.01 42.06 FOOT FRACTURE | 3 0.03 42.09 FOOT OPERATION | 1 0.01 42.10 FORAMINOTOMY | 1 0.01 42.11 FORCED EXPIRATORY VOLUME DECREASED | 1 0.01 42.12 FOREIGN BODY TRAUMA | 3 0.03 42.15 FORMICATION | 2 0.02 42.17 FRACTURE | 3 0.03 42.20 FREQUENT BOWEL MOVEMENTS | 1 0.01 42.21 FRUSTRATION | 1 0.01 42.22 FUNGAL INFECTION | 4 0.04 42.26 FUNGAL PERITONITIS | 1 0.01 42.27 FUNGAL SKIN INFECTION | 1 0.01 42.28 FURUNCLE | 1 0.01 42.29 GAIT DISTURBANCE | 24 0.24 42.53 GALACTORRHOEA | 2 0.02 42.55 GALLBLADDER DISORDER | 4 0.04 42.59 GAMMA-GLUTAMYLTRANSFERASE DECREASED | 1 0.01 42.60 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 8 0.08 42.68 GANGRENE | 3 0.03 42.71 GARDNERELLA INFECTION | 1 0.01 42.72 GASTRECTOMY | 3 0.03 42.75 GASTRIC BANDING | 1 0.01 42.76 GASTRIC BYPASS | 2 0.02 42.78 GASTRIC CANCER | 4 0.04 42.82 GASTRIC DISORDER | 4 0.04 42.86 GASTRIC HAEMORRHAGE | 3 0.03 42.89 GASTRIC PERFORATION | 1 0.01 42.90 GASTRIC ULCER | 7 0.07 42.97 GASTRIC ULCER HAEMORRHAGE | 3 0.03 43.00 GASTRIC ULCER PERFORATION | 2 0.02 43.02 GASTRINOMA | 1 0.01 43.03 GASTRITIS | 2 0.02 43.05 GASTRITIS EROSIVE | 1 0.01 43.06 GASTROENTERITIS | 4 0.04 43.10 GASTROENTERITIS VIRAL | 4 0.04 43.14 GASTROINTESTINAL ARTERIOVENOUS MALFOR.. | 1 0.01 43.15 GASTROINTESTINAL CARCINOMA | 3 0.03 43.18 GASTROINTESTINAL DISORDER | 7 0.07 43.25 GASTROINTESTINAL FUNGAL INFECTION | 1 0.01 43.26 GASTROINTESTINAL HAEMORRHAGE | 16 0.16 43.42 GASTROINTESTINAL INJURY | 1 0.01 43.43 GASTROINTESTINAL NECROSIS | 1 0.01 43.44 GASTROINTESTINAL NEOPLASM | 1 0.01 43.45 GASTROINTESTINAL OEDEMA | 2 0.02 43.47 GASTROINTESTINAL PAIN | 1 0.01 43.48 GASTROINTESTINAL PERFORATION | 1 0.01 43.49 GASTROINTESTINAL SOUNDS ABNORMAL | 1 0.01 43.50 GASTROINTESTINAL TELANGIECTASIA | 1 0.01 43.51 GASTROOESOPHAGEAL REFLUX DISEASE | 17 0.17 43.68 GASTROSCHISIS | 2 0.02 43.70 GAZE PALSY | 1 0.01 43.71 GENERAL PHYSICAL CONDITION ABNORMAL | 2 0.02 43.73 GENERAL PHYSICAL HEALTH DETERIORATION | 21 0.21 43.94 GENERAL SYMPTOM | 1 0.01 43.95 GENERALISED ERYTHEMA | 1 0.01 43.96 GENERALISED OEDEMA | 3 0.03 43.99 GENITAL DISORDER FEMALE | 1 0.01 44.00 GENITAL RASH | 1 0.01 44.01 GIARDIASIS | 1 0.01 44.02 GINGIVAL ABSCESS | 1 0.01 44.03 GINGIVAL BLEEDING | 4 0.04 44.07 GINGIVAL ERYTHEMA | 1 0.01 44.08 GINGIVAL INFECTION | 2 0.02 44.10 GINGIVAL PAIN | 4 0.04 44.14 GINGIVAL RECESSION | 1 0.01 44.15 GINGIVAL SWELLING | 5 0.05 44.20 GINGIVAL ULCERATION | 1 0.01 44.21 GINGIVITIS | 2 0.02 44.23 GLAUCOMA | 4 0.04 44.27 GLIOMA | 1 0.01 44.28 GLOMERULAR FILTRATION RATE DECREASED | 3 0.03 44.31 GLOMERULONEPHRITIS | 3 0.03 44.34 GLOMERULONEPHRITIS MEMBRANOUS | 2 0.02 44.36 GLOSSITIS | 2 0.02 44.38 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 44.39 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEF.. | 1 0.01 44.40 GLYCOSURIA | 1 0.01 44.41 GLYCOSYLATED HAEMOGLOBIN INCREASED | 1 0.01 44.42 GOUT | 1 0.01 44.43 GOUTY ARTHRITIS | 2 0.02 44.45 GRAFT DYSFUNCTION | 2 0.02 44.47 GRAFT VERSUS HOST DISEASE | 2 0.02 44.49 GRAND MAL CONVULSION | 5 0.05 44.54 GRANULOCYTOPENIA | 1 0.01 44.55 GRANULOMA | 1 0.01 44.56 GRIP STRENGTH DECREASED | 1 0.01 44.57 GROIN PAIN | 1 0.01 44.58 GUILLAIN-BARRE SYNDROME | 1 0.01 44.59 GUN SHOT WOUND | 1 0.01 44.60 GYNAECOMASTIA | 1 0.01 44.61 HAEMARTHROSIS | 1 0.01 44.62 HAEMATEMESIS | 13 0.13 44.75 HAEMATOCHEZIA | 8 0.08 44.83 HAEMATOCRIT DECREASED | 6 0.06 44.89 HAEMATOMA | 6 0.06 44.95 HAEMATURIA | 7 0.07 45.02 HAEMOBILIA | 1 0.01 45.03 HAEMODIALYSIS | 1 0.01 45.04 HAEMODYNAMIC INSTABILITY | 1 0.01 45.05 HAEMOGLOBIN | 1 0.01 45.06 HAEMOGLOBIN DECREASED | 21 0.21 45.27 HAEMOLYSIS | 1 0.01 45.28 HAEMOLYTIC ANAEMIA | 2 0.02 45.30 HAEMOPHILUS INFECTION | 1 0.01 45.31 HAEMOPTYSIS | 9 0.09 45.40 HAEMORRHAGE | 23 0.23 45.63 HAEMORRHAGE INTRACRANIAL | 2 0.02 45.65 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 45.66 HAEMORRHAGIC DISORDER | 1 0.01 45.67 HAEMORRHAGIC STROKE | 2 0.02 45.69 HAEMORRHAGIC TUMOUR NECROSIS | 1 0.01 45.70 HAEMORRHOIDS | 5 0.05 45.75 HAEMOSTASIS | 1 0.01 45.76 HAIRY CELL LEUKAEMIA | 1 0.01 45.77 HALLUCINATION | 25 0.25 46.02 HALLUCINATION, AUDITORY | 12 0.12 46.14 HALLUCINATION, VISUAL | 6 0.06 46.20 HALLUCINATIONS, MIXED | 1 0.01 46.21 HAND DEFORMITY | 1 0.01 46.22 HAND FRACTURE | 1 0.01 46.23 HANGOVER | 1 0.01 46.24 HEAD INJURY | 10 0.10 46.34 HEADACHE | 89 0.89 47.23 HEARING IMPAIRED | 3 0.03 47.26 HEART DISEASE CONGENITAL | 3 0.03 47.29 HEART INJURY | 2 0.02 47.31 HEART RATE ABNORMAL | 1 0.01 47.32 HEART RATE DECREASED | 3 0.03 47.35 HEART RATE INCREASED | 14 0.14 47.49 HEART RATE IRREGULAR | 6 0.06 47.55 HEART TRANSPLANT | 1 0.01 47.56 HEART VALVE INCOMPETENCE | 1 0.01 47.57 HEART VALVE STENOSIS | 2 0.02 47.59 HEAT STROKE | 1 0.01 47.60 HELICOBACTER GASTRITIS | 1 0.01 47.61 HELLP SYNDROME | 1 0.01 47.62 HEMIANOPIA | 1 0.01 47.63 HEMIPARESIS | 6 0.06 47.69 HEMIPLEGIA | 1 0.01 47.70 HENOCH-SCHONLEIN PURPURA | 1 0.01 47.71 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 47.72 HEPATIC CANCER METASTATIC | 1 0.01 47.73 HEPATIC CIRRHOSIS | 2 0.02 47.75 HEPATIC CONGESTION | 1 0.01 47.76 HEPATIC ENCEPHALOPATHY | 8 0.08 47.84 HEPATIC ENZYME INCREASED | 10 0.10 47.94 HEPATIC FAILURE | 9 0.09 48.03 HEPATIC FUNCTION ABNORMAL | 13 0.13 48.16 HEPATIC NECROSIS | 1 0.01 48.17 HEPATIC NEOPLASM | 1 0.01 48.18 HEPATIC NEOPLASM MALIGNANT | 5 0.05 48.23 HEPATIC PAIN | 3 0.03 48.26 HEPATIC STEATOSIS | 3 0.03 48.29 HEPATITIS | 13 0.13 48.42 HEPATITIS B | 3 0.03 48.45 HEPATITIS B DNA INCREASED | 1 0.01 48.46 HEPATITIS B E ANTIGEN POSITIVE | 1 0.01 48.47 HEPATITIS C | 3 0.03 48.50 HEPATITIS CHOLESTATIC | 2 0.02 48.52 HEPATITIS FULMINANT | 2 0.02 48.54 HEPATITIS TOXIC | 1 0.01 48.55 HEPATITIS VIRAL | 1 0.01 48.56 HEPATOCELLULAR INJURY | 2 0.02 48.58 HEPATOMEGALY | 2 0.02 48.60 HEPATOTOXICITY | 2 0.02 48.62 HERNIA | 5 0.05 48.67 HERNIA PAIN | 1 0.01 48.68 HERNIA REPAIR | 1 0.01 48.69 HERPES OPHTHALMIC | 1 0.01 48.70 HERPES VIRUS INFECTION | 1 0.01 48.71 HERPES ZOSTER | 5 0.05 48.76 HIATUS HERNIA | 4 0.04 48.80 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 48.81 HIP ARTHROPLASTY | 2 0.02 48.83 HIP FRACTURE | 1 0.01 48.84 HIP SURGERY | 1 0.01 48.85 HIRSUTISM | 2 0.02 48.87 HOMICIDAL IDEATION | 4 0.04 48.91 HORMONE LEVEL ABNORMAL | 1 0.01 48.92 HORNER'S SYNDROME | 1 0.01 48.93 HOSPITALISATION | 13 0.13 49.06 HOSTILITY | 3 0.03 49.09 HOT FLUSH | 19 0.19 49.28 HUMAN EHRLICHIOSIS | 15 0.15 49.43 HUMERUS FRACTURE | 1 0.01 49.44 HUNGER | 1 0.01 49.45 HYDRONEPHROSIS | 3 0.03 49.48 HYPERAESTHESIA | 1 0.01 49.49 HYPERAMMONAEMIA | 4 0.04 49.53 HYPERBILIRUBINAEMIA | 1 0.01 49.54 HYPERCALCAEMIA | 6 0.06 49.60 HYPERCHOLESTEROLAEMIA | 2 0.02 49.62 HYPERCOAGULATION | 1 0.01 49.63 HYPERGLYCAEMIA | 12 0.12 49.75 HYPERHIDROSIS | 29 0.29 50.04 HYPERKALAEMIA | 5 0.05 50.09 HYPERKERATOSIS | 1 0.01 50.10 HYPERLIPIDAEMIA | 6 0.06 50.16 HYPERNATRAEMIA | 3 0.03 50.19 HYPEROSMOLAR STATE | 1 0.01 50.20 HYPERPARATHYROIDISM | 1 0.01 50.21 HYPERPHAGIA | 1 0.01 50.22 HYPERPYREXIA | 1 0.01 50.23 HYPERSENSITIVITY | 23 0.23 50.46 HYPERSEXUALITY | 3 0.03 50.49 HYPERSOMNIA | 6 0.06 50.55 HYPERTENSION | 49 0.49 51.04 HYPERTENSIVE CRISIS | 5 0.05 51.09 HYPERTENSIVE HEART DISEASE | 1 0.01 51.10 HYPERTHERMIA | 2 0.02 51.12 HYPERTHERMIA MALIGNANT | 1 0.01 51.13 HYPERTHYROIDISM | 1 0.01 51.14 HYPERTONIA | 2 0.02 51.16 HYPERTRICHOSIS | 1 0.01 51.17 HYPERTROPHIC CARDIOMYOPATHY | 1 0.01 51.18 HYPERTROPHIC SCAR | 1 0.01 51.19 HYPERURICAEMIA | 1 0.01 51.20 HYPOACUSIS | 1 0.01 51.21 HYPOAESTHESIA | 20 0.20 51.41 HYPOAESTHESIA FACIAL | 2 0.02 51.43 HYPOAESTHESIA ORAL | 3 0.03 51.46 HYPOALBUMINAEMIA | 2 0.02 51.48 HYPOCALCAEMIA | 3 0.03 51.51 HYPOCHROMIC ANAEMIA | 1 0.01 51.52 HYPOGAMMAGLOBULINAEMIA | 1 0.01 51.53 HYPOGLYCAEMIA | 21 0.21 51.74 HYPOGLYCAEMIC COMA | 2 0.02 51.76 HYPOGLYCAEMIC ENCEPHALOPATHY | 1 0.01 51.77 HYPOGLYCAEMIC UNCONSCIOUSNESS | 3 0.03 51.80 HYPOKALAEMIA | 13 0.13 51.93 HYPOKINESIA | 6 0.06 51.99 HYPOMAGNESAEMIA | 3 0.03 52.02 HYPOMANIA | 4 0.04 52.06 HYPOMENORRHOEA | 1 0.01 52.07 HYPONATRAEMIA | 8 0.08 52.15 HYPOPARATHYROIDISM SECONDARY | 1 0.01 52.16 HYPOPHAGIA | 4 0.04 52.20 HYPOPHOSPHATAEMIA | 2 0.02 52.22 HYPOREFLEXIA | 1 0.01 52.23 HYPOTENSION | 33 0.33 52.56 HYPOTHERMIA | 3 0.03 52.59 HYPOTHYROIDISM | 8 0.08 52.67 HYPOTONIA | 2 0.02 52.69 HYPOTONIA NEONATAL | 1 0.01 52.70 HYPOVOLAEMIA | 4 0.04 52.74 HYPOXIA | 11 0.11 52.85 HYSTERECTOMY | 8 0.08 52.93 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 52.94 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2 0.02 52.96 IDIOSYNCRATIC DRUG REACTION | 1 0.01 52.97 ILEUS | 3 0.03 53.00 ILEUS PARALYTIC | 1 0.01 53.01 ILIAC ARTERY THROMBOSIS | 1 0.01 53.02 ILL-DEFINED DISORDER | 9 0.09 53.11 ILLUSION | 1 0.01 53.12 IMMOBILE | 2 0.02 53.14 IMMUNE RECONSTITUTION SYNDROME | 1 0.01 53.15 IMMUNE SYSTEM DISORDER | 1 0.01 53.16 IMMUNODEFICIENCY | 1 0.01 53.17 IMMUNOSUPPRESSION | 2 0.02 53.19 IMPAIRED DRIVING ABILITY | 2 0.02 53.21 IMPAIRED FASTING GLUCOSE | 1 0.01 53.22 IMPAIRED GASTRIC EMPTYING | 2 0.02 53.24 IMPAIRED HEALING | 5 0.05 53.29 IMPAIRED WORK ABILITY | 3 0.03 53.32 IMPLANT SITE EXTRAVASATION | 1 0.01 53.33 IMPULSE-CONTROL DISORDER | 1 0.01 53.34 IMPULSIVE BEHAVIOUR | 1 0.01 53.35 INADEQUATE ANALGESIA | 2 0.02 53.37 INADEQUATE DIET | 1 0.01 53.38 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 2 0.02 53.40 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 4 0.04 53.44 INCISION SITE HAEMORRHAGE | 1 0.01 53.45 INCISION SITE PAIN | 1 0.01 53.46 INCOHERENT | 2 0.02 53.48 INCONTINENCE | 1 0.01 53.49 INCORRECT DOSE ADMINISTERED | 12 0.12 53.61 INCORRECT DRUG ADMINISTRATION DURATION | 1 0.01 53.62 INCORRECT DRUG DOSAGE FORM ADMINISTERED | 1 0.01 53.63 INCORRECT ROUTE OF DRUG ADMINISTRATION | 13 0.13 53.76 INCREASED APPETITE | 4 0.04 53.80 INCREASED BRONCHIAL SECRETION | 2 0.02 53.82 INCREASED UPPER AIRWAY SECRETION | 1 0.01 53.83 INDUCED ABORTION HAEMORRHAGE | 1 0.01 53.84 INFARCTION | 2 0.02 53.86 INFECTED BITES | 2 0.02 53.88 INFECTED SKIN ULCER | 1 0.01 53.89 INFECTION | 20 0.20 54.09 INFECTION SUSCEPTIBILITY INCREASED | 1 0.01 54.10 INFECTIVE THROMBOSIS | 1 0.01 54.11 INFERTILITY MALE | 1 0.01 54.12 INFLAMMATION | 9 0.09 54.21 INFLAMMATORY BOWEL DISEASE | 2 0.02 54.23 INFLUENZA | 9 0.09 54.32 INFLUENZA LIKE ILLNESS | 17 0.17 54.49 INFUSION RELATED REACTION | 7 0.07 54.56 INFUSION SITE INFECTION | 1 0.01 54.57 INFUSION SITE SWELLING | 1 0.01 54.58 INGROWING NAIL | 3 0.03 54.61 INITIAL INSOMNIA | 1 0.01 54.62 INJECTION SITE EROSION | 1 0.01 54.63 INJECTION SITE ERYTHEMA | 6 0.06 54.69 INJECTION SITE HAEMATOMA | 3 0.03 54.72 INJECTION SITE HAEMORRHAGE | 4 0.04 54.76 INJECTION SITE INDURATION | 2 0.02 54.78 INJECTION SITE INFLAMMATION | 1 0.01 54.79 INJECTION SITE IRRITATION | 2 0.02 54.81 INJECTION SITE MASS | 2 0.02 54.83 INJECTION SITE NECROSIS | 1 0.01 54.84 INJECTION SITE OEDEMA | 1 0.01 54.85 INJECTION SITE PAIN | 12 0.12 54.97 INJECTION SITE PRURITUS | 1 0.01 54.98 INJECTION SITE REACTION | 1 0.01 54.99 INJECTION SITE SWELLING | 1 0.01 55.00 INJURY | 12 0.12 55.12 INSOMNIA | 49 0.49 55.61 INSPIRATORY CAPACITY DECREASED | 1 0.01 55.62 INTENTIONAL DRUG MISUSE | 8 0.08 55.70 INTENTIONAL OVERDOSE | 9 0.09 55.79 INTENTIONAL SELF-INJURY | 3 0.03 55.82 INTERCEPTED DRUG ADMINISTRATION ERROR | 1 0.01 55.83 INTERCEPTED MEDICATION ERROR | 1 0.01 55.84 INTERCOSTAL RETRACTION | 1 0.01 55.85 INTERMITTENT CLAUDICATION | 1 0.01 55.86 INTERNATIONAL NORMALISED RATIO ABNORMAL | 1 0.01 55.87 INTERNATIONAL NORMALISED RATIO DECREA.. | 1 0.01 55.88 INTERNATIONAL NORMALISED RATIO FLUCTU.. | 2 0.02 55.90 INTERNATIONAL NORMALISED RATIO INCREA.. | 12 0.12 56.02 INTERSTITIAL LUNG DISEASE | 10 0.10 56.12 INTERVERTEBRAL DISC COMPRESSION | 1 0.01 56.13 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 56.15 INTERVERTEBRAL DISC DISORDER | 1 0.01 56.16 INTERVERTEBRAL DISC PROTRUSION | 4 0.04 56.20 INTESTINAL FUNCTIONAL DISORDER | 3 0.03 56.23 INTESTINAL HAEMORRHAGE | 2 0.02 56.25 INTESTINAL ISCHAEMIA | 2 0.02 56.27 INTESTINAL OBSTRUCTION | 13 0.13 56.40 INTESTINAL PERFORATION | 2 0.02 56.42 INTRA-UTERINE CONTRACEPTIVE DEVICE EX.. | 5 0.05 56.47 INTRA-UTERINE DEATH | 2 0.02 56.49 INTRACRANIAL ANEURYSM | 2 0.02 56.51 INTRACRANIAL HYPOTENSION | 1 0.01 56.52 INTRAOCULAR PRESSURE INCREASED | 7 0.07 56.59 IRIDOCYCLITIS | 1 0.01 56.60 IRIS DISORDER | 1 0.01 56.61 IRON DEFICIENCY ANAEMIA | 2 0.02 56.63 IRRITABILITY | 15 0.15 56.78 IRRITABLE BOWEL SYNDROME | 4 0.04 56.82 ISCHAEMIA | 1 0.01 56.83 ISCHAEMIC CARDIOMYOPATHY | 2 0.02 56.85 ISCHAEMIC LIMB PAIN | 1 0.01 56.86 ISCHAEMIC STROKE | 2 0.02 56.88 IUCD COMPLICATION | 6 0.06 56.94 IUD MIGRATION | 4 0.04 56.98 JAUNDICE | 11 0.11 57.09 JAUNDICE CHOLESTATIC | 1 0.01 57.10 JAUNDICE NEONATAL | 1 0.01 57.11 JAW DISORDER | 3 0.03 57.14 JEJUNECTOMY | 1 0.01 57.15 JOINT ABSCESS | 1 0.01 57.16 JOINT ANKYLOSIS | 2 0.02 57.18 JOINT CREPITATION | 1 0.01 57.19 JOINT DISLOCATION | 3 0.03 57.22 JOINT EFFUSION | 3 0.03 57.25 JOINT INJURY | 2 0.02 57.27 JOINT SPRAIN | 5 0.05 57.32 JOINT STIFFNESS | 2 0.02 57.34 JOINT SWELLING | 14 0.14 57.48 KAPOSI'S SARCOMA | 2 0.02 57.50 KIDNEY FIBROSIS | 1 0.01 57.51 KIDNEY INFECTION | 3 0.03 57.54 KIDNEY TRANSPLANT REJECTION | 1 0.01 57.55 KNEE ARTHROPLASTY | 2 0.02 57.57 KNEE OPERATION | 1 0.01 57.58 LABILE BLOOD PRESSURE | 1 0.01 57.59 LABORATORY TEST ABNORMAL | 1 0.01 57.60 LABYRINTHITIS | 1 0.01 57.61 LACERATION | 1 0.01 57.62 LACRIMATION INCREASED | 4 0.04 57.66 LACTIC ACIDOSIS | 5 0.05 57.71 LAPAROTOMY | 2 0.02 57.73 LARGE INTESTINAL ULCER | 1 0.01 57.74 LARGE INTESTINE PERFORATION | 1 0.01 57.75 LARYNGEAL CANCER | 2 0.02 57.77 LARYNGEAL OEDEMA | 3 0.03 57.80 LARYNGOCELE | 1 0.01 57.81 LARYNGOSPASM | 1 0.01 57.82 LATENT TUBERCULOSIS | 1 0.01 57.83 LEARNING DISORDER | 2 0.02 57.85 LEFT ATRIAL DILATATION | 2 0.02 57.87 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCT.. | 1 0.01 57.88 LEFT VENTRICULAR DYSFUNCTION | 1 0.01 57.89 LEFT VENTRICULAR FAILURE | 1 0.01 57.90 LEFT VENTRICULAR HYPERTROPHY | 5 0.05 57.95 LEG AMPUTATION | 1 0.01 57.96 LEGAL PROBLEM | 1 0.01 57.97 LENS DISORDER | 2 0.02 57.99 LETHARGY | 15 0.15 58.14 LEUKAEMIA | 1 0.01 58.15 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 58.16 LEUKOCYTOSIS | 2 0.02 58.18 LEUKOPENIA | 18 0.18 58.36 LIBIDO INCREASED | 1 0.01 58.37 LICE INFESTATION | 1 0.01 58.38 LICHENOID KERATOSIS | 1 0.01 58.39 LIGAMENT RUPTURE | 2 0.02 58.41 LIMB DISCOMFORT | 1 0.01 58.42 LIMB INJURY | 3 0.03 58.45 LIP AND/OR ORAL CAVITY CANCER | 2 0.02 58.47 LIP DRY | 1 0.01 58.48 LIP EXFOLIATION | 1 0.01 58.49 LIP SWELLING | 2 0.02 58.51 LIPOATROPHY | 1 0.01 58.52 LIPODYSTROPHY ACQUIRED | 1 0.01 58.53 LIPOHYPERTROPHY | 1 0.01 58.54 LIPOMATOSIS | 1 0.01 58.55 LIVEDO RETICULARIS | 1 0.01 58.56 LIVER ABSCESS | 1 0.01 58.57 LIVER DISORDER | 11 0.11 58.68 LIVER FUNCTION TEST ABNORMAL | 14 0.14 58.82 LIVER INJURY | 4 0.04 58.86 LIVER TRANSPLANT | 2 0.02 58.88 LOBAR PNEUMONIA | 1 0.01 58.89 LOCAL SWELLING | 1 0.01 58.90 LOCALISED INFECTION | 1 0.01 58.91 LOCALISED INTRAABDOMINAL FLUID COLLEC.. | 1 0.01 58.92 LOCALISED OEDEMA | 5 0.05 58.97 LOOP ELECTROSURGICAL EXCISION PROCEDURE | 1 0.01 58.98 LOOSE ASSOCIATIONS | 1 0.01 58.99 LOOSE TOOTH | 1 0.01 59.00 LOSS OF CONSCIOUSNESS | 44 0.44 59.44 LOSS OF CONTROL OF LEGS | 1 0.01 59.45 LOW TURNOVER OSTEOPATHY | 2 0.02 59.47 LOWER GASTROINTESTINAL HAEMORRHAGE | 3 0.03 59.50 LOWER LIMB FRACTURE | 2 0.02 59.52 LOWER RESPIRATORY TRACT INFECTION | 10 0.10 59.62 LOWER RESPIRATORY TRACT INFECTION FUN.. | 1 0.01 59.63 LUMBAR RADICULOPATHY | 3 0.03 59.66 LUNG ADENOCARCINOMA | 2 0.02 59.68 LUNG CONSOLIDATION | 1 0.01 59.69 LUNG DISORDER | 14 0.14 59.83 LUNG INFECTION | 2 0.02 59.85 LUNG INFECTION PSEUDOMONAL | 1 0.01 59.86 LUNG INFILTRATION | 4 0.04 59.90 LUNG INJURY | 1 0.01 59.91 LUNG NEOPLASM | 2 0.02 59.93 LUNG NEOPLASM MALIGNANT | 3 0.03 59.96 LUPUS NEPHRITIS | 1 0.01 59.97 LYMPH NODE PAIN | 1 0.01 59.98 LYMPHADENOPATHY | 16 0.16 60.14 LYMPHOCYTE COUNT DECREASED | 3 0.03 60.17 LYMPHOCYTE COUNT INCREASED | 1 0.01 60.18 LYMPHOEDEMA | 2 0.02 60.20 LYMPHOMA | 2 0.02 60.22 LYMPHOPENIA | 5 0.05 60.27 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 60.28 MACULAR DEGENERATION | 5 0.05 60.33 MACULOPATHY | 1 0.01 60.34 MAJOR DEPRESSION | 6 0.06 60.40 MALAISE | 40 0.40 60.80 MALIGNANT MELANOMA | 2 0.02 60.82 MALIGNANT NEOPLASM PROGRESSION | 7 0.07 60.89 MALIGNANT PERITONEAL NEOPLASM | 1 0.01 60.90 MALIGNANT RESPIRATORY TRACT NEOPLASM | 1 0.01 60.91 MALNUTRITION | 1 0.01 60.92 MAMMOGRAM ABNORMAL | 2 0.02 60.94 MANIA | 10 0.10 61.04 MASS | 2 0.02 61.06 MASTICATION DISORDER | 1 0.01 61.07 MATERNAL DRUGS AFFECTING FOETUS | 3 0.03 61.10 MEAN CELL HAEMOGLOBIN INCREASED | 1 0.01 61.11 MEAN CELL VOLUME INCREASED | 1 0.01 61.12 MEAN PLATELET VOLUME DECREASED | 1 0.01 61.13 MECHANICAL VENTILATION | 2 0.02 61.15 MEDIAL TIBIAL STRESS SYNDROME | 1 0.01 61.16 MEDIASTINAL HAEMATOMA | 1 0.01 61.17 MEDICAL OBSERVATION | 1 0.01 61.18 MEDICATION ERROR | 9 0.09 61.27 MELAENA | 1 0.01 61.28 MELANOMA RECURRENT | 1 0.01 61.29 MEMORY IMPAIRMENT | 16 0.16 61.45 MENINGIOMA | 2 0.02 61.47 MENINGISM | 1 0.01 61.48 MENINGITIS | 1 0.01 61.49 MENINGITIS BACTERIAL | 1 0.01 61.50 MENINGITIS MENINGOCOCCAL | 1 0.01 61.51 MENINGITIS PNEUMOCOCCAL | 1 0.01 61.52 MENINGITIS VIRAL | 2 0.02 61.54 MENOPAUSE | 2 0.02 61.56 MENORRHAGIA | 13 0.13 61.69 MENSTRUAL DISORDER | 2 0.02 61.71 MENSTRUATION DELAYED | 1 0.01 61.72 MENSTRUATION IRREGULAR | 3 0.03 61.75 MENTAL DISORDER | 8 0.08 61.83 MENTAL IMPAIRMENT | 2 0.02 61.85 MENTAL RETARDATION | 1 0.01 61.86 MENTAL STATUS CHANGES | 10 0.10 61.96 MESENTERIC VEIN THROMBOSIS | 3 0.03 61.99 METABOLIC ACIDOSIS | 2 0.02 62.01 METABOLIC DISORDER | 1 0.01 62.02 METABOLIC ENCEPHALOPATHY | 8 0.08 62.10 METAMORPHOPSIA | 3 0.03 62.13 METASTASES TO BONE | 1 0.01 62.14 METASTASES TO CENTRAL NERVOUS SYSTEM | 3 0.03 62.17 METASTASES TO LIVER | 2 0.02 62.19 METASTASES TO LUNG | 2 0.02 62.21 METASTASES TO LYMPH NODES | 1 0.01 62.22 METASTASIS | 3 0.03 62.25 METASTATIC RENAL CELL CARCINOMA | 1 0.01 62.26 METASTATIC UTERINE CANCER | 1 0.01 62.27 METRORRHAGIA | 9 0.09 62.36 MICROALBUMINURIA | 1 0.01 62.37 MICROANGIOPATHY | 1 0.01 62.38 MICROCYTIC ANAEMIA | 2 0.02 62.40 MICTURITION DISORDER | 1 0.01 62.41 MICTURITION URGENCY | 3 0.03 62.44 MIDDLE EAR EFFUSION | 1 0.01 62.45 MIDDLE INSOMNIA | 4 0.04 62.49 MIGRAINE | 21 0.21 62.70 MILK ALLERGY | 1 0.01 62.71 MIOSIS | 1 0.01 62.72 MITRAL VALVE DISEASE | 2 0.02 62.74 MITRAL VALVE INCOMPETENCE | 7 0.07 62.81 MOBILITY DECREASED | 10 0.10 62.91 MONARTHRITIS | 1 0.01 62.92 MONONUCLEOSIS SYNDROME | 1 0.01 62.93 MOOD ALTERED | 12 0.12 63.05 MOOD SWINGS | 13 0.13 63.18 MORBID THOUGHTS | 1 0.01 63.19 MOTOR DYSFUNCTION | 2 0.02 63.21 MOTOR NEURONE DISEASE | 2 0.02 63.23 MOUNTAIN SICKNESS ACUTE | 1 0.01 63.24 MOUTH INJURY | 1 0.01 63.25 MOUTH ULCERATION | 5 0.05 63.30 MOVEMENT DISORDER | 6 0.06 63.36 MUCOSAL INFLAMMATION | 11 0.11 63.47 MUCOUS STOOLS | 1 0.01 63.48 MULTI-ORGAN FAILURE | 10 0.10 63.58 MULTIPLE CARDIAC DEFECTS | 1 0.01 63.59 MULTIPLE DRUG OVERDOSE | 1 0.01 63.60 MULTIPLE DRUG OVERDOSE INTENTIONAL | 3 0.03 63.63 MULTIPLE INJURIES | 2 0.02 63.65 MULTIPLE MYELOMA | 5 0.05 63.70 MULTIPLE SCLEROSIS | 9 0.09 63.79 MULTIPLE SCLEROSIS RELAPSE | 11 0.11 63.90 MUSCLE ATROPHY | 2 0.02 63.92 MUSCLE CONTRACTIONS INVOLUNTARY | 2 0.02 63.94 MUSCLE CONTRACTURE | 1 0.01 63.95 MUSCLE DISORDER | 2 0.02 63.97 MUSCLE ENZYME INCREASED | 2 0.02 63.99 MUSCLE INJURY | 1 0.01 64.00 MUSCLE NECROSIS | 1 0.01 64.01 MUSCLE RIGIDITY | 2 0.02 64.03 MUSCLE SPASMS | 22 0.22 64.25 MUSCLE SPASTICITY | 1 0.01 64.26 MUSCLE STRAIN | 3 0.03 64.29 MUSCLE TIGHTNESS | 1 0.01 64.30 MUSCLE TWITCHING | 3 0.03 64.33 MUSCULAR WEAKNESS | 26 0.26 64.59 MUSCULOSKELETAL CHEST PAIN | 3 0.03 64.62 MUSCULOSKELETAL DISCOMFORT | 2 0.02 64.64 MUSCULOSKELETAL DISORDER | 3 0.03 64.67 MUSCULOSKELETAL PAIN | 15 0.15 64.82 MUSCULOSKELETAL STIFFNESS | 11 0.11 64.93 MYALGIA | 40 0.40 65.33 MYCOSIS FUNGOIDES | 1 0.01 65.34 MYDRIASIS | 3 0.03 65.37 MYELITIS TRANSVERSE | 1 0.01 65.38 MYELODYSPLASTIC SYNDROME | 3 0.03 65.41 MYELOFIBROSIS | 2 0.02 65.43 MYELOPROLIFERATIVE DISORDER | 1 0.01 65.44 MYOCARDIAL INFARCTION | 57 0.57 66.01 MYOCARDIAL ISCHAEMIA | 25 0.25 66.26 MYOCARDITIS | 2 0.02 66.28 MYOCLONIC EPILEPSY | 1 0.01 66.29 MYOCLONUS | 2 0.02 66.31 MYODESOPSIA | 2 0.02 66.33 MYOGLOBIN BLOOD INCREASED | 1 0.01 66.34 MYOKYMIA | 1 0.01 66.35 MYOPATHY | 6 0.06 66.41 MYOPIA | 2 0.02 66.43 MYOSITIS | 3 0.03 66.46 NAIL DISORDER | 1 0.01 66.47 NAIL DYSTROPHY | 1 0.01 66.48 NAIL OPERATION | 1 0.01 66.49 NASAL CONGESTION | 2 0.02 66.51 NASAL DRYNESS | 1 0.01 66.52 NASAL INFLAMMATION | 1 0.01 66.53 NASAL POLYPS | 1 0.01 66.54 NASAL VESTIBULITIS | 1 0.01 66.55 NASOPHARYNGITIS | 19 0.19 66.74 NAUSEA | 126 1.26 68.00 NECK INJURY | 2 0.02 68.02 NECK MASS | 2 0.02 68.04 NECK PAIN | 10 0.10 68.14 NECROSIS | 1 0.01 68.15 NECROSIS ISCHAEMIC | 1 0.01 68.16 NECROTISING FASCIITIS | 1 0.01 68.17 NEGATIVE THOUGHTS | 1 0.01 68.18 NEONATAL RESPIRATORY DISTRESS SYNDROME | 3 0.03 68.21 NEOPLASM | 1 0.01 68.22 NEOPLASM MALIGNANT | 5 0.05 68.27 NEOPLASM OF APPENDIX | 1 0.01 68.28 NEOPLASM PROGRESSION | 2 0.02 68.30 NEPHROGENIC ANAEMIA | 1 0.01 68.31 NEPHROGENIC SYSTEMIC FIBROSIS | 5 0.05 68.36 NEPHROLITHIASIS | 11 0.11 68.47 NEPHROPATHY | 1 0.01 68.48 NEPHROPATHY TOXIC | 3 0.03 68.51 NEPHROSCLEROSIS | 1 0.01 68.52 NEPHROTIC SYNDROME | 3 0.03 68.55 NERVE COMPRESSION | 2 0.02 68.57 NERVOUS SYSTEM DISORDER | 5 0.05 68.62 NERVOUSNESS | 14 0.14 68.76 NEURALGIA | 2 0.02 68.78 NEURODERMATITIS | 1 0.01 68.79 NEUROLEPTIC MALIGNANT SYNDROME | 7 0.07 68.86 NEUROLOGICAL DECOMPENSATION | 2 0.02 68.88 NEUROPATHY PERIPHERAL | 11 0.11 68.99 NEUTRALISING ANTIBODIES POSITIVE | 1 0.01 69.00 NEUTROPENIA | 20 0.20 69.20 NEUTROPENIC SEPSIS | 2 0.02 69.22 NEUTROPHIL COUNT ABNORMAL | 1 0.01 69.23 NEUTROPHIL COUNT DECREASED | 7 0.07 69.30 NEUTROPHIL COUNT INCREASED | 4 0.04 69.34 NICOTINE DEPENDENCE | 1 0.01 69.35 NIGHT SWEATS | 6 0.06 69.41 NIGHTMARE | 4 0.04 69.45 NO ADVERSE EVENT | 17 0.17 69.62 NO THERAPEUTIC RESPONSE | 1 0.01 69.63 NOCTURIA | 4 0.04 69.67 NOCTURNAL DYSPNOEA | 1 0.01 69.68 NON-NEUTRALISING ANTIBODIES POSITIVE | 1 0.01 69.69 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 69.70 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 69.71 NUTRITIONAL CONDITION ABNORMAL | 1 0.01 69.72 OBESITY | 6 0.06 69.78 OBLITERATIVE BRONCHIOLITIS | 1 0.01 69.79 OBSESSIVE THOUGHTS | 1 0.01 69.80 OBSESSIVE-COMPULSIVE DISORDER | 8 0.08 69.88 OBSTRUCTION GASTRIC | 1 0.01 69.89 OBSTRUCTIVE AIRWAYS DISORDER | 3 0.03 69.92 OCCULT BLOOD POSITIVE | 1 0.01 69.93 OCCUPATIONAL EXPOSURE TO TOXIC AGENT | 1 0.01 69.94 OCULAR HYPERAEMIA | 10 0.10 70.04 OCULAR ICTERUS | 2 0.02 70.06 OCULAR SARCOIDOSIS | 1 0.01 70.07 OCULOAURICULOVERTEBRAL DYSPLASIA | 1 0.01 70.08 OEDEMA | 13 0.13 70.21 OEDEMA GENITAL | 1 0.01 70.22 OEDEMA MOUTH | 3 0.03 70.25 OEDEMA PERIPHERAL | 45 0.45 70.70 OEDEMATOUS PANCREATITIS | 1 0.01 70.71 OESOPHAGEAL ATRESIA | 1 0.01 70.72 OESOPHAGEAL SPASM | 1 0.01 70.73 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 1 0.01 70.74 OESOPHAGEAL STENOSIS | 1 0.01 70.75 OESOPHAGEAL VARICES HAEMORRHAGE | 1 0.01 70.76 OESOPHAGITIS | 3 0.03 70.79 OESOPHAGITIS ULCERATIVE | 1 0.01 70.80 OESOPHAGOGASTRIC FUNDOPLASTY | 1 0.01 70.81 OESTROGEN RECEPTOR ASSAY POSITIVE | 1 0.01 70.82 OFF LABEL USE | 6 0.06 70.88 OLIGOMENORRHOEA | 1 0.01 70.89 OLIGURIA | 1 0.01 70.90 ONYCHOMYCOSIS | 1 0.01 70.91 OOPHORECTOMY | 1 0.01 70.92 OPERATIVE HAEMORRHAGE | 2 0.02 70.94 OPISTHOTONUS | 1 0.01 70.95 OPTIC ISCHAEMIC NEUROPATHY | 1 0.01 70.96 OPTIC NERVE INFARCTION | 1 0.01 70.97 OPTIC NEURITIS | 1 0.01 70.98 ORAL CANDIDIASIS | 2 0.02 71.00 ORAL CAVITY FISTULA | 2 0.02 71.02 ORAL DISCOMFORT | 1 0.01 71.03 ORAL DISORDER | 1 0.01 71.04 ORAL HERPES | 2 0.02 71.06 ORAL INFECTION | 1 0.01 71.07 ORAL MUCOSAL ERYTHEMA | 1 0.01 71.08 ORAL NEOPLASM | 1 0.01 71.09 ORAL PAIN | 4 0.04 71.13 ORGAN FAILURE | 1 0.01 71.14 OROPHARYNGEAL BLISTERING | 3 0.03 71.17 OROPHARYNGEAL PAIN | 11 0.11 71.28 OROPHARYNGEAL PLAQUE | 1 0.01 71.29 OROPHARYNGEAL SPASM | 1 0.01 71.30 ORTHOPEDIC PROCEDURE | 1 0.01 71.31 ORTHOPNOEA | 1 0.01 71.32 ORTHOSTATIC HYPOTENSION | 5 0.05 71.37 OSTEITIS | 3 0.03 71.40 OSTEITIS DEFORMANS | 1 0.01 71.41 OSTEOARTHRITIS | 8 0.08 71.49 OSTEOGENESIS IMPERFECTA | 2 0.02 71.51 OSTEOMYELITIS | 12 0.12 71.63 OSTEONECROSIS | 32 0.32 71.95 OSTEOPENIA | 4 0.04 71.99 OSTEOPOROSIS | 9 0.09 72.08 OTITIS MEDIA | 2 0.02 72.10 OVARIAN ADHESION | 1 0.01 72.11 OVARIAN CANCER | 1 0.01 72.12 OVARIAN CYST | 4 0.04 72.16 OVERDOSE | 27 0.27 72.43 OVERWEIGHT | 1 0.01 72.44 OXYGEN SATURATION DECREASED | 8 0.08 72.52 PAIN | 71 0.71 73.23 PAIN IN EXTREMITY | 39 0.39 73.62 PAIN IN JAW | 11 0.11 73.73 PAIN OF SKIN | 1 0.01 73.74 PALLOR | 5 0.05 73.79 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 16 0.16 73.95 PALPITATIONS | 19 0.19 74.14 PANCREATIC CARCINOMA | 8 0.08 74.22 PANCREATIC DISORDER | 1 0.01 74.23 PANCREATIC MASS | 1 0.01 74.24 PANCREATIC PSEUDOCYST | 1 0.01 74.25 PANCREATITIS | 22 0.22 74.47 PANCREATITIS ACUTE | 3 0.03 74.50 PANCREATITIS CHRONIC | 4 0.04 74.54 PANCREATITIS NECROTISING | 1 0.01 74.55 PANCYTOPENIA | 13 0.13 74.68 PANIC ATTACK | 12 0.12 74.80 PANIC DISORDER | 2 0.02 74.82 PANIC DISORDER WITH AGORAPHOBIA | 1 0.01 74.83 PANIC REACTION | 1 0.01 74.84 PARACENTESIS | 1 0.01 74.85 PARADOXICAL PRESSOR RESPONSE | 1 0.01 74.86 PARAESTHESIA | 20 0.20 75.06 PARAESTHESIA ORAL | 1 0.01 75.07 PARALYSIS | 9 0.09 75.16 PARANASAL SINUS HYPERSECRETION | 1 0.01 75.17 PARANOIA | 12 0.12 75.29 PARAPLEGIA | 1 0.01 75.30 PARATHYROID TUMOUR BENIGN | 1 0.01 75.31 PARATHYROIDECTOMY | 1 0.01 75.32 PARKINSON'S DISEASE | 4 0.04 75.36 PARKINSONIAN REST TREMOR | 1 0.01 75.37 PARONYCHIA | 1 0.01 75.38 PAROSMIA | 2 0.02 75.40 PARTIAL SEIZURES | 1 0.01 75.41 PARTNER STRESS | 1 0.01 75.42 PARVOVIRUS B19 SEROLOGY POSITIVE | 1 0.01 75.43 PATELLOFEMORAL PAIN SYNDROME | 1 0.01 75.44 PATENT DUCTUS ARTERIOSUS | 7 0.07 75.51 PATERNAL DRUGS AFFECTING FOETUS | 3 0.03 75.54 PATHOLOGICAL FRACTURE | 2 0.02 75.56 PATHOLOGICAL GAMBLING | 5 0.05 75.61 PEAK EXPIRATORY FLOW RATE DECREASED | 2 0.02 75.63 PELVIC ABSCESS | 2 0.02 75.65 PELVIC FRACTURE | 3 0.03 75.68 PELVIC PAIN | 9 0.09 75.77 PELVIC VENOUS THROMBOSIS | 1 0.01 75.78 PEMPHIGUS | 2 0.02 75.80 PEPTIC ULCER | 2 0.02 75.82 PEPTIC ULCER HAEMORRHAGE | 1 0.01 75.83 PERCUTANEOUS CORONARY INTERVENTION | 1 0.01 75.84 PERFORMANCE STATUS DECREASED | 3 0.03 75.87 PERIARTHRITIS | 1 0.01 75.88 PERICARDIAL EFFUSION | 5 0.05 75.93 PERICARDITIS MALIGNANT | 1 0.01 75.94 PERIODONTITIS | 1 0.01 75.95 PERIORBITAL HAEMATOMA | 1 0.01 75.96 PERIORBITAL OEDEMA | 1 0.01 75.97 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 75.98 PERIPHERAL COLDNESS | 4 0.04 76.02 PERIPHERAL ISCHAEMIA | 2 0.02 76.04 PERIPHERAL MOTOR NEUROPATHY | 1 0.01 76.05 PERIPHERAL VASCULAR DISORDER | 5 0.05 76.10 PERITONEAL ADHESIONS | 1 0.01 76.11 PERITONITIS | 4 0.04 76.15 PERITONITIS BACTERIAL | 1 0.01 76.16 PERIUMBILICAL ABSCESS | 1 0.01 76.17 PERSECUTORY DELUSION | 1 0.01 76.18 PERSISTENT FOETAL CIRCULATION | 3 0.03 76.21 PERSONALITY CHANGE | 3 0.03 76.24 PERSONALITY DISORDER | 1 0.01 76.25 PETECHIAE | 2 0.02 76.27 PHAEOCHROMOCYTOMA | 1 0.01 76.28 PHARYNGEAL DISORDER | 1 0.01 76.29 PHARYNGEAL OEDEMA | 6 0.06 76.35 PHARYNGITIS | 6 0.06 76.41 PHARYNGITIS STREPTOCOCCAL | 3 0.03 76.44 PHLEBITIS | 6 0.06 76.50 PHOBIA | 1 0.01 76.51 PHOTOPHOBIA | 3 0.03 76.54 PHOTOPSIA | 1 0.01 76.55 PICKWICKIAN SYNDROME | 1 0.01 76.56 PIGMENTATION DISORDER | 4 0.04 76.60 PILONIDAL CYST | 1 0.01 76.61 PITTING OEDEMA | 2 0.02 76.63 PLACENTA PRAEVIA | 1 0.01 76.64 PLAGIOCEPHALY | 1 0.01 76.65 PLATELET COUNT DECREASED | 17 0.17 76.82 PLATELET COUNT INCREASED | 1 0.01 76.83 PLATELET TRANSFUSION | 1 0.01 76.84 PLEURAL EFFUSION | 15 0.15 76.99 PLEURAL FIBROSIS | 1 0.01 77.00 PLEURISY | 4 0.04 77.04 PNEUMOCYSTIS JIROVECI INFECTION | 1 0.01 77.05 PNEUMOCYSTIS JIROVECI PNEUMONIA | 4 0.04 77.09 PNEUMONIA | 55 0.55 77.64 PNEUMONIA ASPIRATION | 8 0.08 77.72 PNEUMONIA BACTERIAL | 2 0.02 77.74 PNEUMONIA KLEBSIELLA | 1 0.01 77.75 PNEUMONIA LEGIONELLA | 1 0.01 77.76 PNEUMONITIS | 4 0.04 77.80 PNEUMOTHORAX | 2 0.02 77.82 PO2 | 1 0.01 77.83 POLLAKIURIA | 3 0.03 77.86 POLYARTHRITIS | 1 0.01 77.87 POLYDACTYLY | 1 0.01 77.88 POLYDIPSIA | 7 0.07 77.95 POLYDIPSIA PSYCHOGENIC | 1 0.01 77.96 POLYMYALGIA RHEUMATICA | 4 0.04 78.00 POLYNEUROPATHY | 2 0.02 78.02 POLYP | 2 0.02 78.04 POLYP COLORECTAL | 1 0.01 78.05 POLYPECTOMY | 1 0.01 78.06 POLYSUBSTANCE DEPENDENCE | 1 0.01 78.07 POLYURIA | 2 0.02 78.09 POOR PERIPHERAL CIRCULATION | 2 0.02 78.11 POOR QUALITY SLEEP | 3 0.03 78.14 POOR VENOUS ACCESS | 1 0.01 78.15 PORIOMANIA | 1 0.01 78.16 PORTAL HYPERTENSION | 1 0.01 78.17 POST CONCUSSION SYNDROME | 1 0.01 78.18 POST LUMBAR PUNCTURE SYNDROME | 1 0.01 78.19 POST PROCEDURAL BILE LEAK | 1 0.01 78.20 POST PROCEDURAL COMPLICATION | 5 0.05 78.25 POST PROCEDURAL HAEMORRHAGE | 3 0.03 78.28 POST-TRAUMATIC STRESS DISORDER | 3 0.03 78.31 POSTURE ABNORMAL | 2 0.02 78.33 PRE-ECLAMPSIA | 1 0.01 78.34 PREGNANCY | 7 0.07 78.41 PREGNANCY INDUCED HYPERTENSION | 1 0.01 78.42 PREGNANCY ON ORAL CONTRACEPTIVE | 3 0.03 78.45 PREGNANCY WITH CONTRACEPTIVE DEVICE | 3 0.03 78.48 PREMATURE BABY | 11 0.11 78.59 PREMATURE LABOUR | 4 0.04 78.63 PREMATURE RUPTURE OF MEMBRANES | 1 0.01 78.64 PREMENSTRUAL SYNDROME | 1 0.01 78.65 PRESSURE OF SPEECH | 2 0.02 78.67 PRESYNCOPE | 5 0.05 78.72 PRIMARY SEQUESTRUM | 3 0.03 78.75 PROCEDURAL COMPLICATION | 2 0.02 78.77 PROCEDURAL NAUSEA | 1 0.01 78.78 PROCEDURAL PAIN | 6 0.06 78.84 PROCEDURAL SITE REACTION | 1 0.01 78.85 PROCTALGIA | 1 0.01 78.86 PRODUCT QUALITY ISSUE | 25 0.25 79.11 PRODUCT SUBSTITUTION ISSUE | 1 0.01 79.12 PRODUCTIVE COUGH | 4 0.04 79.16 PROGESTERONE RECEPTOR ASSAY POSITIVE | 1 0.01 79.17 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 5 0.05 79.22 PROLACTINOMA | 1 0.01 79.23 PROPIONIBACTERIUM INFECTION | 1 0.01 79.24 PROSTATE CANCER | 6 0.06 79.30 PROSTATE INFECTION | 1 0.01 79.31 PROSTATIC HAEMORRHAGE | 1 0.01 79.32 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 79.33 PROSTATITIS | 1 0.01 79.34 PROSTATOMEGALY | 1 0.01 79.35 PROTEIN URINE PRESENT | 1 0.01 79.36 PROTEINURIA | 2 0.02 79.38 PROTHROMBIN TIME PROLONGED | 4 0.04 79.42 PRURIGO | 1 0.01 79.43 PRURITUS | 33 0.33 79.76 PRURITUS GENERALISED | 7 0.07 79.83 PSEUDOMONAS INFECTION | 3 0.03 79.86 PSOAS ABSCESS | 1 0.01 79.87 PSORIASIS | 5 0.05 79.92 PSYCHIATRIC DECOMPENSATION | 2 0.02 79.94 PSYCHIATRIC SYMPTOM | 1 0.01 79.95 PSYCHOGENIC PAIN DISORDER | 1 0.01 79.96 PSYCHOMOTOR HYPERACTIVITY | 6 0.06 80.02 PSYCHOMOTOR RETARDATION | 1 0.01 80.03 PSYCHOTIC BEHAVIOUR | 1 0.01 80.04 PSYCHOTIC DISORDER | 16 0.16 80.20 PSYCHOTIC DISORDER DUE TO A GENERAL M.. | 1 0.01 80.21 PTERYGIUM | 1 0.01 80.22 PULMONARY ALVEOLAR HAEMORRHAGE | 1 0.01 80.23 PULMONARY ARTERIAL HYPERTENSION | 2 0.02 80.25 PULMONARY ARTERIAL PRESSURE INCREASED | 1 0.01 80.26 PULMONARY ARTERY STENOSIS CONGENITAL | 2 0.02 80.28 PULMONARY ARTERY THROMBOSIS | 1 0.01 80.29 PULMONARY CONGESTION | 6 0.06 80.35 PULMONARY EMBOLISM | 22 0.22 80.57 PULMONARY FIBROSIS | 4 0.04 80.61 PULMONARY HAEMORRHAGE | 2 0.02 80.63 PULMONARY HYPERTENSION | 4 0.04 80.67 PULMONARY INFARCTION | 1 0.01 80.68 PULMONARY MALFORMATION | 1 0.01 80.69 PULMONARY MYCOSIS | 1 0.01 80.70 PULMONARY OEDEMA | 17 0.17 80.87 PULMONARY PNEUMATOCELE | 1 0.01 80.88 PULMONARY TOXICITY | 2 0.02 80.90 PULMONARY TUBERCULOSIS | 1 0.01 80.91 PULMONARY VALVE INCOMPETENCE | 1 0.01 80.92 PULMONARY VALVE STENOSIS | 5 0.05 80.97 PULSE ABSENT | 2 0.02 80.99 PULSE PRESSURE INCREASED | 1 0.01 81.00 PUPILLARY DISORDER | 1 0.01 81.01 PUPILLARY LIGHT REFLEX TESTS ABNORMAL | 1 0.01 81.02 PUPILLARY REFLEX IMPAIRED | 1 0.01 81.03 PURULENCE | 1 0.01 81.04 PURULENT DISCHARGE | 6 0.06 81.10 PYELONEPHRITIS | 4 0.04 81.14 PYREXIA | 94 0.94 82.08 QRS AXIS ABNORMAL | 1 0.01 82.09 QUALITY OF LIFE DECREASED | 1 0.01 82.10 RADIATION SKIN INJURY | 1 0.01 82.11 RADICAL PROSTATECTOMY | 2 0.02 82.13 RADICULITIS CERVICAL | 1 0.01 82.14 RADICULITIS LUMBOSACRAL | 1 0.01 82.15 RALES | 5 0.05 82.20 RASH | 54 0.54 82.74 RASH ERYTHEMATOUS | 3 0.03 82.77 RASH GENERALISED | 7 0.07 82.84 RASH MACULAR | 4 0.04 82.88 RASH MACULO-PAPULAR | 3 0.03 82.91 RASH PAPULAR | 5 0.05 82.96 RASH PRURITIC | 9 0.09 83.05 RASH PUSTULAR | 2 0.02 83.07 RASH VESICULAR | 1 0.01 83.08 RAYNAUD'S PHENOMENON | 1 0.01 83.09 REACTION TO DRUG EXCIPIENTS | 2 0.02 83.11 REACTION TO PRESERVATIVES | 1 0.01 83.12 REACTIVE PSYCHOSIS | 1 0.01 83.13 RECTAL HAEMORRHAGE | 8 0.08 83.21 RECTAL PROLAPSE | 1 0.01 83.22 RECTOCELE | 2 0.02 83.24 RECURRENT CANCER | 1 0.01 83.25 RED BLOOD CELL COUNT DECREASED | 4 0.04 83.29 REFLUX LARYNGITIS | 1 0.01 83.30 REFLUX NEPHROPATHY | 1 0.01 83.31 REFLUX OESOPHAGITIS | 1 0.01 83.32 REFUSAL OF TREATMENT BY PATIENT | 2 0.02 83.34 REFUSAL OF TREATMENT BY RELATIVE | 1 0.01 83.35 REGURGITATION | 2 0.02 83.37 REHABILITATION THERAPY | 1 0.01 83.38 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 1 0.01 83.39 RENAL ABSCESS | 1 0.01 83.40 RENAL AMYLOIDOSIS | 1 0.01 83.41 RENAL APLASIA | 1 0.01 83.42 RENAL ARTERY OCCLUSION | 1 0.01 83.43 RENAL CANCER | 3 0.03 83.46 RENAL CELL CARCINOMA | 1 0.01 83.47 RENAL COLIC | 2 0.02 83.49 RENAL CYST | 1 0.01 83.50 RENAL DISORDER | 11 0.11 83.61 RENAL FAILURE | 26 0.26 83.87 RENAL FAILURE ACUTE | 27 0.27 84.14 RENAL FAILURE CHRONIC | 5 0.05 84.19 RENAL FUNCTION TEST ABNORMAL | 3 0.03 84.22 RENAL HAEMORRHAGE | 1 0.01 84.23 RENAL HYPOPLASIA | 1 0.01 84.24 RENAL IMPAIRMENT | 23 0.23 84.47 RENAL INFARCT | 1 0.01 84.48 RENAL PAIN | 4 0.04 84.52 REPETITIVE SPEECH | 1 0.01 84.53 RESORPTION BONE INCREASED | 1 0.01 84.54 RESPIRATORY ARREST | 4 0.04 84.58 RESPIRATORY DEPRESSION | 3 0.03 84.61 RESPIRATORY DISORDER | 10 0.10 84.71 RESPIRATORY DISTRESS | 9 0.09 84.80 RESPIRATORY FAILURE | 14 0.14 84.94 RESPIRATORY RATE INCREASED | 1 0.01 84.95 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOL.. | 1 0.01 84.96 RESPIRATORY TRACT CONGESTION | 1 0.01 84.97 RESPIRATORY TRACT INFECTION | 5 0.05 85.02 RESTLESS LEGS SYNDROME | 5 0.05 85.07 RESTLESSNESS | 11 0.11 85.18 RESTRICTIVE PULMONARY DISEASE | 1 0.01 85.19 RETCHING | 1 0.01 85.20 RETINAL DETACHMENT | 5 0.05 85.25 RETINAL HAEMORRHAGE | 1 0.01 85.26 RETINAL INJURY | 1 0.01 85.27 RETINAL SCAR | 1 0.01 85.28 RETINAL TEAR | 1 0.01 85.29 RETINOPATHY | 2 0.02 85.31 RETROPERITONEAL ABSCESS | 1 0.01 85.32 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 2 0.02 85.34 RHABDOMYOLYSIS | 13 0.13 85.47 RHABDOMYOSARCOMA RECURRENT | 1 0.01 85.48 RHEUMATOID ARTHRITIS | 6 0.06 85.54 RHINITIS | 5 0.05 85.59 RHINITIS ALLERGIC | 2 0.02 85.61 RHINORRHOEA | 4 0.04 85.65 RIB FRACTURE | 3 0.03 85.68 RIGHT ATRIAL DILATATION | 2 0.02 85.70 RIGHT VENTRICULAR FAILURE | 2 0.02 85.72 RIGHT VENTRICULAR HYPERTROPHY | 2 0.02 85.74 ROAD TRAFFIC ACCIDENT | 17 0.17 85.91 ROTATOR CUFF SYNDROME | 2 0.02 85.93 SACROILIITIS | 2 0.02 85.95 SALIVARY GLAND DISORDER | 1 0.01 85.96 SALIVARY HYPERSECRETION | 3 0.03 85.99 SARCOIDOSIS | 1 0.01 86.00 SARCOMA METASTATIC | 1 0.01 86.01 SCAPULA FRACTURE | 1 0.01 86.02 SCAR | 7 0.07 86.09 SCHIZOAFFECTIVE DISORDER | 4 0.04 86.13 SCHIZOID PERSONALITY DISORDER | 1 0.01 86.14 SCHIZOPHRENIA | 3 0.03 86.17 SCHIZOPHRENIA, PARANOID TYPE | 3 0.03 86.20 SCHIZOPHRENIA, UNDIFFERENTIATED TYPE | 1 0.01 86.21 SCIATICA | 2 0.02 86.23 SCOLIOSIS | 3 0.03 86.26 SCOTOMA | 1 0.01 86.27 SCRATCH | 2 0.02 86.29 SCREAMING | 1 0.01 86.30 SEBORRHOEIC DERMATITIS | 1 0.01 86.31 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 1 0.01 86.32 SECRETION DISCHARGE | 1 0.01 86.33 SEDATION | 7 0.07 86.40 SEIZURE ANOXIC | 1 0.01 86.41 SELECTIVE ABORTION | 1 0.01 86.42 SELF INJURIOUS BEHAVIOUR | 3 0.03 86.45 SELF-INJURIOUS IDEATION | 1 0.01 86.46 SELF-MEDICATION | 1 0.01 86.47 SEMEN VOLUME DECREASED | 1 0.01 86.48 SENSATION OF FOREIGN BODY | 1 0.01 86.49 SENSATION OF HEAVINESS | 2 0.02 86.51 SENSE OF OPPRESSION | 1 0.01 86.52 SENSORY DISTURBANCE | 5 0.05 86.57 SENSORY LOSS | 2 0.02 86.59 SEPSIS | 26 0.26 86.85 SEPTIC SHOCK | 9 0.09 86.94 SEQUESTRECTOMY | 2 0.02 86.96 SEROMA | 1 0.01 86.97 SEROTONIN SYNDROME | 2 0.02 86.99 SERUM FERRITIN INCREASED | 1 0.01 87.00 SHIFT TO THE LEFT | 1 0.01 87.01 SHOCK | 7 0.07 87.08 SIGMOIDITIS | 1 0.01 87.09 SINUS ARRHYTHMIA | 1 0.01 87.10 SINUS BRADYCARDIA | 5 0.05 87.15 SINUS DISORDER | 2 0.02 87.17 SINUS TACHYCARDIA | 5 0.05 87.22 SINUSITIS | 8 0.08 87.30 SKIN BURNING SENSATION | 1 0.01 87.31 SKIN CANCER | 3 0.03 87.34 SKIN CANDIDA | 1 0.01 87.35 SKIN DISCOLOURATION | 7 0.07 87.42 SKIN DISORDER | 7 0.07 87.49 SKIN EXFOLIATION | 7 0.07 87.56 SKIN FISSURES | 2 0.02 87.58 SKIN GRAFT | 1 0.01 87.59 SKIN HYPERPIGMENTATION | 1 0.01 87.60 SKIN INDURATION | 1 0.01 87.61 SKIN INFECTION | 3 0.03 87.64 SKIN LACERATION | 3 0.03 87.67 SKIN LESION | 5 0.05 87.72 SKIN NECROSIS | 2 0.02 87.74 SKIN NEOPLASM EXCISION | 1 0.01 87.75 SKIN NODULE | 2 0.02 87.77 SKIN ODOUR ABNORMAL | 2 0.02 87.79 SKIN PAPILLOMA | 1 0.01 87.80 SKIN REACTION | 3 0.03 87.83 SKIN TIGHTNESS | 1 0.01 87.84 SKIN TOXICITY | 3 0.03 87.87 SKIN TURGOR DECREASED | 1 0.01 87.88 SKIN ULCER | 6 0.06 87.94 SKIN WARM | 2 0.02 87.96 SKULL MALFORMATION | 2 0.02 87.98 SLEEP APNOEA SYNDROME | 9 0.09 88.07 SLEEP DISORDER | 16 0.16 88.23 SLEEP TALKING | 1 0.01 88.24 SLEEP TERROR | 1 0.01 88.25 SLUGGISHNESS | 1 0.01 88.26 SMALL INTESTINAL OBSTRUCTION | 3 0.03 88.29 SMALL INTESTINAL PERFORATION | 1 0.01 88.30 SMALL INTESTINAL STENOSIS | 1 0.01 88.31 SNEEZING | 4 0.04 88.35 SNORING | 2 0.02 88.37 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 88.38 SOCIAL PROBLEM | 2 0.02 88.40 SOFT TISSUE INFECTION | 1 0.01 88.41 SOMATOFORM DISORDER | 2 0.02 88.43 SOMNAMBULISM | 6 0.06 88.49 SOMNOLENCE | 34 0.34 88.83 SOPOR | 2 0.02 88.85 SPEECH DISORDER | 12 0.12 88.97 SPEECH DISORDER DEVELOPMENTAL | 1 0.01 88.98 SPERM COUNT INCREASED | 1 0.01 88.99 SPERMATOZOA ABNORMAL | 1 0.01 89.00 SPINAL CORD COMPRESSION | 1 0.01 89.01 SPINAL CORD INFARCTION | 5 0.05 89.06 SPINAL CORD INJURY | 1 0.01 89.07 SPINAL CORD ISCHAEMIA | 1 0.01 89.08 SPINAL DISORDER | 1 0.01 89.09 SPINAL FRACTURE | 3 0.03 89.12 SPINAL FUSION SURGERY | 2 0.02 89.14 SPINAL OSTEOARTHRITIS | 3 0.03 89.17 SPINE MALFORMATION | 1 0.01 89.18 SPLENIC INFARCTION | 1 0.01 89.19 SPLENOMEGALY | 2 0.02 89.21 SPONDYLITIS | 1 0.01 89.22 SPONTANEOUS HAEMATOMA | 1 0.01 89.23 STAPHYLOCOCCAL INFECTION | 10 0.10 89.33 STAPHYLOCOCCAL SEPSIS | 3 0.03 89.36 STAPHYLOCOCCAL SKIN INFECTION | 1 0.01 89.37 STARING | 1 0.01 89.38 STASIS SYNDROME | 1 0.01 89.39 STATUS ASTHMATICUS | 1 0.01 89.40 STENT PLACEMENT | 6 0.06 89.46 STEREOTYPY | 1 0.01 89.47 STERNAL FRACTURE | 1 0.01 89.48 STEVENS-JOHNSON SYNDROME | 6 0.06 89.54 STILLBIRTH | 1 0.01 89.55 STOMATITIS | 7 0.07 89.62 STRESS | 11 0.11 89.73 STRESS CARDIOMYOPATHY | 4 0.04 89.77 STRESS URINARY INCONTINENCE | 2 0.02 89.79 STRIDOR | 2 0.02 89.81 SUBARACHNOID HAEMORRHAGE | 4 0.04 89.85 SUBCUTANEOUS ABSCESS | 2 0.02 89.87 SUBDURAL HAEMATOMA | 5 0.05 89.92 SUBSTANCE ABUSE | 3 0.03 89.95 SUDDEN DEATH | 2 0.02 89.97 SUDDEN INFANT DEATH SYNDROME | 1 0.01 89.98 SUFFOCATION FEELING | 1 0.01 89.99 SUICIDAL BEHAVIOUR | 1 0.01 90.00 SUICIDAL IDEATION | 34 0.34 90.34 SUICIDE ATTEMPT | 21 0.21 90.55 SUNBURN | 1 0.01 90.56 SUPERINFECTION | 1 0.01 90.57 SUPERINFECTION BACTERIAL | 1 0.01 90.58 SUPERIOR SAGITTAL SINUS THROMBOSIS | 1 0.01 90.59 SUPRAPUBIC PAIN | 1 0.01 90.60 SUPRAVENTRICULAR EXTRASYSTOLES | 3 0.03 90.63 SUPRAVENTRICULAR TACHYCARDIA | 2 0.02 90.65 SURGERY | 10 0.10 90.75 SURGICAL PROCEDURE REPEATED | 1 0.01 90.76 SUSPICIOUSNESS | 1 0.01 90.77 SUTURE RELATED COMPLICATION | 2 0.02 90.79 SUTURE RUPTURE | 1 0.01 90.80 SWEAT DISCOLOURATION | 1 0.01 90.81 SWELLING | 8 0.08 90.89 SWELLING FACE | 9 0.09 90.98 SWOLLEN TONGUE | 7 0.07 91.05 SYNCOPE | 21 0.21 91.26 SYNDACTYLY | 1 0.01 91.27 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 1 0.01 91.28 SYSTEMIC LUPUS ERYTHEMATOSUS | 2 0.02 91.30 SYSTEMIC LUPUS ERYTHEMATOSUS RASH | 1 0.01 91.31 SYSTEMIC SCLEROSIS | 1 0.01 91.32 T-CELL LYMPHOMA | 1 0.01 91.33 T-CELL TYPE ACUTE LEUKAEMIA | 1 0.01 91.34 TACHYCARDIA | 12 0.12 91.46 TACHYPNOEA | 4 0.04 91.50 TARDIVE DYSKINESIA | 6 0.06 91.56 TEARFULNESS | 1 0.01 91.57 TEMPERATURE INTOLERANCE | 1 0.01 91.58 TENDERNESS | 1 0.01 91.59 TENDON DISORDER | 1 0.01 91.60 TENDON INJURY | 1 0.01 91.61 TENDON RUPTURE | 2 0.02 91.63 TENDONITIS | 2 0.02 91.65 TENSION | 2 0.02 91.67 TESTICULAR CYST | 1 0.01 91.68 TESTICULAR PAIN | 1 0.01 91.69 THERAPEUTIC AGENT TOXICITY | 2 0.02 91.71 THERAPEUTIC EMBOLISATION | 1 0.01 91.72 THERAPEUTIC RESPONSE DECREASED | 9 0.09 91.81 THERAPEUTIC RESPONSE UNEXPECTED | 2 0.02 91.83 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 11 0.11 91.94 THERAPY CESSATION | 1 0.01 91.95 THERMAL BURN | 2 0.02 91.97 THINKING ABNORMAL | 5 0.05 92.02 THORACIC VERTEBRAL FRACTURE | 1 0.01 92.03 THROAT CANCER | 1 0.01 92.04 THROAT IRRITATION | 6 0.06 92.10 THROAT TIGHTNESS | 1 0.01 92.11 THROMBECTOMY | 1 0.01 92.12 THROMBOCYTHAEMIA | 2 0.02 92.14 THROMBOCYTOPENIA | 31 0.31 92.45 THROMBOPHLEBITIS SUPERFICIAL | 1 0.01 92.46 THROMBOSIS | 15 0.15 92.61 THROMBOSIS MESENTERIC VESSEL | 1 0.01 92.62 THROMBOTIC STROKE | 1 0.01 92.63 THYMOMA MALIGNANT | 1 0.01 92.64 THYMUS DISORDER | 1 0.01 92.65 THYROGLOSSAL CYST | 1 0.01 92.66 THYROID CANCER | 2 0.02 92.68 THYROID FUNCTION TEST ABNORMAL | 1 0.01 92.69 TIBIA FRACTURE | 1 0.01 92.70 TINNITUS | 4 0.04 92.74 TOBACCO POISONING | 1 0.01 92.75 TOBACCO USER | 4 0.04 92.79 TONGUE BITING | 1 0.01 92.80 TONGUE DRY | 2 0.02 92.82 TONGUE NECROSIS | 1 0.01 92.83 TONIC CONVULSION | 1 0.01 92.84 TONSILLAR HYPERTROPHY | 1 0.01 92.85 TONSILLITIS | 1 0.01 92.86 TOOTH DEPOSIT | 1 0.01 92.87 TOOTH DISORDER | 1 0.01 92.88 TOOTH EXTRACTION | 10 0.10 92.98 TOOTH FRACTURE | 3 0.03 93.01 TOOTH HYPOPLASIA | 1 0.01 93.02 TOOTH INFECTION | 1 0.01 93.03 TOOTHACHE | 3 0.03 93.06 TORSADE DE POINTES | 2 0.02 93.08 TOTAL LUNG CAPACITY DECREASED | 1 0.01 93.09 TOURETTE'S DISORDER | 1 0.01 93.10 TOXIC ENCEPHALOPATHY | 1 0.01 93.11 TOXIC EPIDERMAL NECROLYSIS | 5 0.05 93.16 TOXIC SHOCK SYNDROME | 1 0.01 93.17 TOXIC SKIN ERUPTION | 3 0.03 93.20 TRACHEAL MASS | 1 0.01 93.21 TRACHEO-OESOPHAGEAL FISTULA | 2 0.02 93.23 TRANSAMINASES INCREASED | 6 0.06 93.29 TRANSFUSION | 1 0.01 93.30 TRANSIENT ISCHAEMIC ATTACK | 14 0.14 93.44 TRANSPLANT FAILURE | 1 0.01 93.45 TRANSPLANT REJECTION | 2 0.02 93.47 TRANSPOSITION OF THE GREAT VESSELS | 3 0.03 93.50 TRANSURETHRAL PROSTATECTOMY | 1 0.01 93.51 TRAUMATIC BRAIN INJURY | 3 0.03 93.54 TREATMENT FAILURE | 3 0.03 93.57 TREATMENT NONCOMPLIANCE | 10 0.10 93.67 TREMOR | 29 0.29 93.96 TRICHIASIS | 1 0.01 93.97 TRICHOMONIASIS | 1 0.01 93.98 TRICUSPID VALVE DISEASE | 3 0.03 94.01 TRICUSPID VALVE INCOMPETENCE | 6 0.06 94.07 TRIGGER FINGER | 1 0.01 94.08 TRISMUS | 1 0.01 94.09 TRISOMY 8 | 2 0.02 94.11 TROPONIN INCREASED | 1 0.01 94.12 TUBERCULIN TEST POSITIVE | 1 0.01 94.13 TUBERCULOSIS | 3 0.03 94.16 TUMOUR EXCISION | 1 0.01 94.17 TUMOUR NECROSIS | 1 0.01 94.18 TYPE 1 DIABETES MELLITUS | 4 0.04 94.22 TYPE 2 DIABETES MELLITUS | 18 0.18 94.40 ULCERATIVE KERATITIS | 1 0.01 94.41 ULTRASOUND ANTENATAL SCREEN ABNORMAL | 2 0.02 94.43 UMBILICAL CORD ABNORMALITY | 1 0.01 94.44 UNDERDOSE | 4 0.04 94.48 UNDERWEIGHT | 1 0.01 94.49 UNEVALUABLE EVENT | 7 0.07 94.56 UNINTENDED PREGNANCY | 1 0.01 94.57 UNRESPONSIVE TO STIMULI | 5 0.05 94.62 UPPER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 94.64 UPPER LIMB FRACTURE | 3 0.03 94.67 UPPER RESPIRATORY TRACT INFECTION | 7 0.07 94.74 URETERAL DISORDER | 1 0.01 94.75 URETERIC OBSTRUCTION | 2 0.02 94.77 URINARY INCONTINENCE | 10 0.10 94.87 URINARY RETENTION | 9 0.09 94.96 URINARY TRACT DISORDER | 2 0.02 94.98 URINARY TRACT INFECTION | 33 0.33 95.31 URINARY TRACT INFECTION BACTERIAL | 2 0.02 95.33 URINARY TRACT INFECTION ENTEROCOCCAL | 1 0.01 95.34 URINARY TRACT INFECTION FUNGAL | 1 0.01 95.35 URINARY TRACT INFECTION PSEUDOMONAL | 1 0.01 95.36 URINARY TRACT INFLAMMATION | 1 0.01 95.37 URINE FLOW DECREASED | 1 0.01 95.38 URINE OUTPUT DECREASED | 3 0.03 95.41 URINE OUTPUT INCREASED | 1 0.01 95.42 URINE SODIUM INCREASED | 1 0.01 95.43 UROSEPSIS | 2 0.02 95.45 URTICARIA | 29 0.29 95.74 UTERINE ATONY | 3 0.03 95.77 UTERINE CYST | 2 0.02 95.79 UTERINE DILATION AND CURETTAGE | 1 0.01 95.80 UTERINE DISORDER | 1 0.01 95.81 UTERINE HAEMORRHAGE | 4 0.04 95.85 UTERINE INFECTION | 1 0.01 95.86 UTERINE LEIOMYOMA | 5 0.05 95.91 UTERINE PAIN | 1 0.01 95.92 UTERINE POLYP | 2 0.02 95.94 UTERINE RUPTURE | 10 0.10 96.04 UTERINE SPASM | 2 0.02 96.06 UVEITIS | 4 0.04 96.10 VACCINATION FAILURE | 1 0.01 96.11 VAGINAL DISCHARGE | 2 0.02 96.13 VAGINAL HAEMORRHAGE | 16 0.16 96.29 VAGINAL SWELLING | 1 0.01 96.30 VARICES OESOPHAGEAL | 1 0.01 96.31 VASCULAR GRAFT | 1 0.01 96.32 VASCULITIS | 2 0.02 96.34 VASODILATATION | 1 0.01 96.35 VEIN DISORDER | 1 0.01 96.36 VENOOCCLUSIVE DISEASE | 1 0.01 96.37 VENOOCCLUSIVE LIVER DISEASE | 2 0.02 96.39 VENOUS INJURY | 1 0.01 96.40 VENOUS LIGATION | 1 0.01 96.41 VENOUS STENOSIS | 1 0.01 96.42 VENOUS THROMBOSIS | 3 0.03 96.45 VENTRICULAR ARRHYTHMIA | 1 0.01 96.46 VENTRICULAR DYSFUNCTION | 1 0.01 96.47 VENTRICULAR EXTRASYSTOLES | 5 0.05 96.52 VENTRICULAR FIBRILLATION | 2 0.02 96.54 VENTRICULAR HYPOKINESIA | 1 0.01 96.55 VENTRICULAR HYPOPLASIA | 2 0.02 96.57 VENTRICULAR SEPTAL DEFECT | 8 0.08 96.65 VENTRICULAR TACHYCARDIA | 3 0.03 96.68 VERBAL ABUSE | 1 0.01 96.69 VERTEBRAL COLUMN MASS | 1 0.01 96.70 VERTIGO | 10 0.10 96.80 VERTIGO POSITIONAL | 1 0.01 96.81 VESICOURETERIC REFLUX | 1 0.01 96.82 VESTIBULAR DISORDER | 1 0.01 96.83 VICTIM OF ABUSE | 1 0.01 96.84 VIOLENCE-RELATED SYMPTOM | 4 0.04 96.88 VIRAL INFECTION | 6 0.06 96.94 VIRAL LOAD INCREASED | 1 0.01 96.95 VISION BLURRED | 27 0.27 97.22 VISUAL ACUITY REDUCED | 8 0.08 97.30 VISUAL FIELD DEFECT | 2 0.02 97.32 VISUAL IMPAIRMENT | 12 0.12 97.44 VITAL CAPACITY DECREASED | 1 0.01 97.45 VITAMIN B12 DEFICIENCY | 1 0.01 97.46 VITAMIN D DEFICIENCY | 2 0.02 97.48 VITAMIN K DEFICIENCY | 1 0.01 97.49 VITREOUS DETACHMENT | 2 0.02 97.51 VITREOUS HAEMORRHAGE | 1 0.01 97.52 VITREOUS OPACITIES | 2 0.02 97.54 VOCAL CORD PARALYSIS | 4 0.04 97.58 VOMITING | 95 0.95 98.53 VULVOVAGINAL BURNING SENSATION | 1 0.01 98.54 VULVOVAGINAL CANDIDIASIS | 2 0.02 98.56 VULVOVAGINAL DISCOMFORT | 1 0.01 98.57 VULVOVAGINAL DRYNESS | 2 0.02 98.59 VULVOVAGINAL PAIN | 1 0.01 98.60 WAIST CIRCUMFERENCE INCREASED | 1 0.01 98.61 WALKING DISABILITY | 1 0.01 98.62 WEIGHT DECREASED | 38 0.38 99.00 WEIGHT FLUCTUATION | 1 0.01 99.01 WEIGHT GAIN POOR | 1 0.01 99.02 WEIGHT INCREASED | 28 0.28 99.30 WHEEZING | 8 0.08 99.38 WHITE BLOOD CELL COUNT ABNORMAL | 2 0.02 99.40 WHITE BLOOD CELL COUNT DECREASED | 17 0.17 99.57 WHITE BLOOD CELL COUNT INCREASED | 6 0.06 99.63 WITHDRAWAL SYNDROME | 3 0.03 99.66 WOUND | 2 0.02 99.68 WOUND DEHISCENCE | 1 0.01 99.69 WOUND HAEMORRHAGE | 1 0.01 99.70 WOUND INFECTION | 3 0.03 99.73 WOUND INFECTION PSEUDOMONAS | 1 0.01 99.74 WOUND SECRETION | 1 0.01 99.75 WRIST FRACTURE | 2 0.02 99.77 WRONG DRUG ADMINISTERED | 3 0.03 99.80 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 16 0.16 99.96 XEROSIS | 1 0.01 99.97 YELLOW SKIN | 3 0.03 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015